Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2012);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Region;Publisher;Coverage;Categories
1;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;10.673;Q1;210;26;54;3020;1317;54;24.54;116.15;United States;Northern America;Annual Reviews Inc.;1965-1973, 1975-2021;"Pharmacology (Q1); Toxicology (Q1)"
2;21191;Pharmacological Reviews;journal;15210081, 00316997;10.673;Q1;241;36;74;12166;1833;74;25.73;337.94;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1949, 1951-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
3;4700152457;Nano Today;journal;17480132;7.995;Q1;155;65;176;4074;2276;128;11.47;62.68;Netherlands;Western Europe;Elsevier;1970, 2006-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
4;20425;Nature Reviews Drug Discovery;journal;14741784, 14741776;6.54;Q1;348;219;663;7676;7040;437;10.58;35.05;United Kingdom;Western Europe;Nature Publishing Group;2002-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
5;22321;Trends in Pharmacological Sciences;journal;18733735, 01656147;5.103;Q1;225;86;252;5885;2967;238;10.47;68.43;United Kingdom;Western Europe;Elsevier Ltd.;1979-2021;"Pharmacology (Q1); Toxicology (Q1)"
6;18017;Neuropsychopharmacology;journal;0893133X, 1470634X;4.716;Q1;227;282;758;18037;6205;723;8.23;63.96;United Kingdom;Western Europe;Nature Publishing Group;1987-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
7;19409;Advanced Drug Delivery Reviews;journal;0169409X, 18728294;4.499;Q1;331;180;380;22774;5298;337;13.46;126.52;Netherlands;Western Europe;Elsevier;1987-2021;Pharmaceutical Science (Q1)
8;21195;Pharmacology and Therapeutics;journal;1879016X, 01637258;3.668;Q1;211;108;307;19821;3129;303;9.37;183.53;United States;Northern America;Elsevier Inc.;1975-1977, 1979-1985, 1987-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
9;26371;Natural Product Reports;journal;02650568, 14604752;3.623;Q1;188;72;242;10736;2492;233;9.99;149.11;United Kingdom;Western Europe;Royal Society of Chemistry;1984-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
10;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;3.403;Q1;233;293;899;30443;6365;889;6.42;103.9;Switzerland;Western Europe;Birkhauser Verlag Basel;1952, 1997-2021;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
11;12611;Drug Resistance Updates;journal;13687646, 15322084;3.276;Q1;119;26;62;3117;624;60;10.13;119.88;United States;Northern America;Churchill Livingstone;1998-2021;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
12;12455;Molecular Therapy;journal;15250024, 15250016;3.234;Q1;185;270;800;11046;5533;693;6.82;40.91;United States;Northern America;Cell Press;2000-2021;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
13;4400151524;Particle and Fibre Toxicology;journal;17438977;3.221;Q1;105;49;106;2648;1112;102;10.44;54.04;United Kingdom;Western Europe;BioMed Central Ltd.;2004-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
14;18148;Pain;journal;18726623, 03043959;3.094;Q1;269;364;1182;15117;6064;882;4.86;41.53;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1975-2021;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
15;110172;Progress in Drug Research;book series;0071786X;3.084;Q1;44;0;15;0;91;13;6.07;0;Switzerland;Western Europe;Birkhauser Verlag Basel;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-2018;"Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
16;20681;Current Opinion in Pharmacology;journal;14714973, 14714892;2.89;Q1;139;116;338;5865;2299;310;5.91;50.56;Netherlands;Western Europe;Elsevier BV;2001-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
17;21100456838;Cell Chemical Biology;journal;24519448, 24519456;2.809;Q1;190;194;534;8184;2625;486;4.9;42.19;United States;Northern America;Elsevier Inc.;2016-2021;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
18;5100155080;Neurotherapeutics;journal;19337213;2.526;Q1;122;67;196;6383;1350;182;6.88;95.27;United States;Northern America;Springer New York;2007-2021;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
19;19907;Medicinal Research Reviews;journal;01986325, 10981128;2.488;Q1;134;38;76;6847;642;74;7.53;180.18;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
20;19963;Molecular Pharmacology;journal;15210111, 0026895X;2.471;Q1;202;203;720;9301;3953;720;5.04;45.82;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1965-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
21;23010;Journal of Controlled Release;journal;18734995, 01683659;2.454;Q1;282;529;1314;30674;8570;1234;5.89;57.98;Netherlands;Western Europe;Elsevier;1984-2021;Pharmaceutical Science (Q1)
22;24749;Addiction Biology;journal;13556215, 13691600;2.436;Q1;83;93;162;5233;907;157;5.44;56.27;United States;Northern America;Wiley-Blackwell;1996-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
23;15984;Journal of Molecular Medicine;journal;09462716, 14321440;2.401;Q1;146;128;381;6704;1917;363;4.86;52.38;Germany;Western Europe;Springer Verlag;1976-1978, 1980-1981, 1995-2021;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
24;4000149101;Nanomedicine: Nanotechnology, Biology, and Medicine;journal;15499634, 15499642;2.379;Q1;133;161;264;6872;2262;257;8.39;42.68;United States;Northern America;Elsevier Inc.;2005-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
25;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2.363;Q1;269;995;2659;33968;13888;2507;5.03;34.14;United States;Northern America;American Society for Microbiology;1963-1970, 1972-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
26;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;2.343;Q1;276;885;2276;42637;13415;2271;5.94;48.18;United States;Northern America;American Chemical Society;1959-1961, 1963-2021;"Drug Discovery (Q1); Molecular Medicine (Q1)"
27;20435;Neuropharmacology;journal;00283908, 18737064;2.315;Q1;176;408;798;31474;4091;782;4.38;77.14;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;"Cellular and Molecular Neuroscience (Q1); Pharmacology (Q1)"
28;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;2.283;Q1;203;529;1564;13759;7639;1219;5.04;26.01;United Kingdom;Western Europe;Oxford University Press;1975-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
29;20624;Clinical Pharmacokinetics;journal;11791926, 03125963;2.254;Q1;169;56;179;4291;1204;160;6.92;76.63;United Kingdom;Western Europe;Adis International Ltd;1976-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
30;19427;Advances in Pharmacology;journal;15578925, 10543589;2.207;Q1;78;34;86;5270;420;10;5.31;155;United States;Northern America;Academic Press Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
31;21000196010;Topics in antiviral medicine;journal;21615861, 21615853;2.177;Q1;43;22;59;346;323;58;5.61;15.73;United States;Northern America;International Antiviral Society;2011-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Virology (Q1)"
32;11900154404;PLoS Neglected Tropical Diseases;journal;19352727, 19352735;2.157;Q1;143;525;1020;23887;5525;981;5.16;45.5;United States;Northern America;Public Library of Science;2007-2021;"Infectious Diseases (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1)"
33;20626;Clinical Pharmacology and Therapeutics;journal;15326535, 00099236;2.155;Q1;195;263;804;8679;4322;680;5.36;33;United States;Northern America;Wiley-Blackwell;1960-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
34;130126;Molecular Pharmaceutics;journal;15438384, 15438392;2.152;Q1;138;350;657;15789;3977;644;5.4;45.11;United States;Northern America;American Chemical Society;2004-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmaceutical Science (Q1)"
35;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;2.131;Q1;113;127;377;7517;1862;359;4.77;59.19;United Kingdom;Western Europe;Oxford University Press;1998-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
36;5400152706;Nanotoxicology;journal;17435390, 17435404;2.104;Q1;94;75;127;3530;956;123;7.11;47.07;United Kingdom;Western Europe;Informa Healthcare;2007-2021;"Biomedical Engineering (Q1); Nanoscience and Nanotechnology (Q1); Toxicology (Q1)"
37;16876;Bioconjugate Chemistry;journal;15204812, 10431802;2.064;Q1;177;258;873;11563;4673;868;5.28;44.82;United States;Northern America;American Chemical Society;1990-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
38;23916;Environmental Pollution;journal;02697491, 18736424;2.038;Q1;249;429;1418;20283;6309;1400;4.11;47.28;United Kingdom;Western Europe;Elsevier Ltd.;1970-1980, 1986-2022;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
39;21782;Psychopharmacology;journal;00333158, 14322072;2.038;Q1;202;407;1069;23686;4708;1029;4.3;58.2;Germany;Western Europe;Springer Verlag;1959-2021;Pharmacology (Q1)
40;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;2.025;Q1;117;42;117;5856;825;112;7.06;139.43;United Kingdom;Western Europe;Informa Healthcare;1971-2021;Toxicology (Q1)
41;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;18733441, 09396411;1.99;Q1;168;235;587;9095;3340;576;4.64;38.7;Netherlands;Western Europe;Elsevier;1991-2021;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
42;21196;Drug Discovery Today;journal;18785832, 13596446;1.967;Q1;185;170;433;10127;2852;392;6.12;59.57;United Kingdom;Western Europe;Elsevier Ltd.;1996-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
43;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;1.963;Q1;115;109;365;4996;1818;362;4.45;45.83;Netherlands;Western Europe;Springer Netherlands;1996-2021;"Biochemistry (medical) (Q1); Cancer Research (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cell Biology (Q2)"
44;15576;European Neuropsychopharmacology;journal;0924977X, 18737862;1.955;Q1;118;109;304;5208;1420;296;4.7;47.78;Netherlands;Western Europe;Elsevier;1990-2021;"Biological Psychiatry (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
45;20677;Current Opinion in Drug Discovery and Development;journal;13676733;1.905;Q1;81;0;141;0;750;135;4.97;0;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
46;4000148019;AAPS Journal;journal;15507416;1.902;Q1;118;99;225;4246;1347;217;4.46;42.89;United States;Northern America;Springer New York;1999-2021;Pharmaceutical Science (Q1)
47;84948;Expert Opinion on Drug Delivery;journal;17425247;1.895;Q1;116;118;308;10235;1920;306;5.79;86.74;United Kingdom;Western Europe;Taylor and Francis Ltd.;2004-2021;Pharmaceutical Science (Q1)
48;21123;Pharmaceutical Research;journal;07248741, 1573904X;1.895;Q1;213;277;788;11163;4513;743;5.48;40.3;United States;Northern America;Springer New York;1984-2021;"Biotechnology (Q1); Molecular Medicine (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
49;20063;Biochemical Pharmacology;journal;18732968, 00062952;1.877;Q1;206;352;1107;20176;5851;990;5.11;57.32;United States;Northern America;Elsevier Inc.;1958-2021;"Biochemistry (Q1); Pharmacology (Q1)"
50;4700152903;Forensic Toxicology;journal;18608965, 18608973;1.845;Q1;39;29;61;567;168;54;3.03;19.55;Japan;Asiatic Region;Springer Japan;2006-2021;"Biochemistry (medical) (Q1); Pathology and Forensic Medicine (Q1); Toxicology (Q1)"
51;25218;Toxicological Sciences;journal;10960929, 10966080;1.812;Q1;193;292;885;13467;4567;843;4.67;46.12;United Kingdom;Western Europe;Oxford University Press;1981-2021;Toxicology (Q1)
52;20084;British Journal of Pharmacology;journal;14765381, 00071188;1.811;Q1;223;558;1570;36495;7528;1501;5.08;65.4;United States;Northern America;Wiley-Blackwell;1965-2021;Pharmacology (Q1)
53;21165;PharmacoEconomics;journal;11707690, 11792027;1.798;Q1;104;88;285;3813;982;238;3.04;43.33;United Kingdom;Western Europe;Adis International Ltd;1992-2021;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
54;26380;Drug and Alcohol Dependence;journal;03768716;1.794;Q1;173;324;822;15795;3277;798;3.49;48.75;Ireland;Western Europe;Elsevier Ireland Ltd;1975-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
55;29311;Current Cancer Drug Targets;journal;15680096, 18735576;1.789;Q1;96;89;255;9901;1285;238;4.29;111.25;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Cancer Research (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
56;21354;Expert Opinion on Therapeutic Targets;journal;14728222, 17447631;1.788;Q1;94;138;337;11271;1537;335;4.37;81.67;United Kingdom;Western Europe;Taylor and Francis Ltd.;1997-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
57;21237;Drug Safety;journal;01145916, 11791942;1.778;Q1;131;111;298;4616;1171;235;3.4;41.59;United Kingdom;Western Europe;Adis International Ltd;1990-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
58;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.693;Q1;159;254;749;11679;2841;714;3.52;45.98;United States;Northern America;Wiley-Blackwell;1977-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
59;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.689;Q1;233;340;1319;14533;5937;1312;4.42;42.74;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1945-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
60;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;18784216, 02785846;1.688;Q1;134;191;881;11206;3052;678;3.28;58.67;United States;Northern America;Elsevier Inc.;1982-2022;"Pharmacology (Q1); Biological Psychiatry (Q2)"
61;144771;Clinical Trials;journal;17407753, 17407745;1.648;Q1;67;88;223;2079;459;182;1.99;23.63;United Kingdom;Western Europe;SAGE Publications Ltd;2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
62;11700154733;Journal of Biomedical Nanotechnology;journal;15507041, 15507033;1.628;Q1;80;108;350;4543;2510;345;7.56;42.06;United States;Northern America;American Scientific Publishers;2007-2020;"Bioengineering (Q1); Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
63;4000148203;Handbook of Experimental Pharmacology;journal;01712004;1.613;Q1;96;152;373;17166;1701;345;3.98;112.93;Germany;Western Europe;Springer Heidelberg;2004-2021;"Biochemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
64;11700154316;CNS Neuroscience and Therapeutics;journal;17555949, 17555930;1.604;Q1;75;164;170;6428;788;152;4.73;39.2;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Physiology (medical) (Q1); Psychiatry and Mental Health (Q1)"
65;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.604;Q1;182;276;883;9390;3782;881;3.81;34.02;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1973-2021;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
66;19600166320;Protein and Cell;journal;16748018, 1674800X;1.603;Q1;74;111;253;5196;735;237;2.91;46.81;China;Asiatic Region;Higher Education Press;2010-2021;"Biochemistry (Q1); Biotechnology (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Cell Biology (Q2)"
67;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;1.599;Q1;90;63;148;2727;785;144;5.37;43.29;United Kingdom;Western Europe;Nature Publishing Group;2001-2021;"Molecular Medicine (Q1); Pharmacology (Q1); Genetics (Q2)"
68;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.578;Q1;175;326;898;16585;4444;872;4.46;50.87;United States;Northern America;Academic Press Inc.;1959-2021;"Pharmacology (Q1); Toxicology (Q1)"
69;22072;Current Gene Therapy;journal;18755631, 15665232;1.565;Q1;75;45;141;5121;693;127;5.3;113.8;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2)"
70;19600166302;Current Molecular Pharmacology;journal;18744702;1.56;Q1;42;39;59;3998;290;57;4.38;102.51;United Arab Emirates;Middle East;Bentham Science Publishers;2008-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
71;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1.556;Q1;100;18;103;2906;560;99;5.19;161.44;United States;Northern America;Informa Healthcare;1972-2021;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
72;22454;International Journal of Pharmaceutics;journal;18733476, 03785173;1.552;Q1;229;709;1847;26113;8361;1829;4.17;36.83;Netherlands;Western Europe;Elsevier;1978-2021;Pharmaceutical Science (Q1)
73;23488;Current Medicinal Chemistry;journal;09298673, 1875533X;1.538;Q1;183;504;1001;59089;5144;970;4.55;117.24;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1994-2021;"Pharmacology (Q1); Molecular Medicine (Q2)"
74;19700177127;ACS Medicinal Chemistry Letters;journal;19485875;1.518;Q1;73;210;283;4877;1009;282;3.57;23.22;United States;Northern America;American Chemical Society;2010-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
75;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1.515;Q1;89;23;76;1791;445;75;4.71;77.87;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
76;4700152872;Journal of NeuroImmune Pharmacology;journal;15571890, 15571904;1.51;Q1;77;92;167;6131;734;158;3.54;66.64;United States;Northern America;Springer New York;2006-2021;"Immunology and Allergy (Q1); Pharmacology (Q1); Immunology (Q2); Neuroscience (miscellaneous) (Q2)"
77;110112;Journal of Immunotherapy;journal;15249557, 15374513;1.497;Q1;97;78;269;3261;1054;264;4.09;41.81;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1991-2021;"Immunology and Allergy (Q1); Pharmacology (Q1); Cancer Research (Q2); Immunology (Q2)"
78;21169;Pharmacological Research;journal;10436618, 10961186;1.493;Q1;147;136;422;7748;2238;406;5.25;56.97;United States;Northern America;Academic Press Inc.;1989-2021;Pharmacology (Q1)
79;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;1.492;Q1;90;123;237;9055;911;208;3.67;73.62;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Neuroscience (miscellaneous) (Q2)"
80;21351;Expert Opinion on Investigational Drugs;journal;13543784, 17447658;1.486;Q1;109;161;456;12444;2052;446;4.29;77.29;United Kingdom;Western Europe;Taylor and Francis Ltd.;1994-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
81;28792;Cancer Biology and Therapy;journal;15384047, 15558576;1.478;Q1;120;175;957;7253;2957;744;3.15;41.45;United States;Northern America;Landes Bioscience;2002-2021;"Oncology (Q1); Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)"
82;14144;Experimental and Clinical Psychopharmacology;journal;19362293, 10641297;1.472;Q1;95;57;150;2870;521;150;3.03;50.35;United States;Northern America;American Psychological Association;1993-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
83;20679;Current Opinion in Investigational Drugs;journal;20403429, 14724472;1.47;Q1;79;0;280;0;1138;268;4.13;0;United Kingdom;Western Europe;Current Drugs Ltd.;2000-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
84;145164;Human Genomics;journal;14739542, 14797364;1.462;Q1;59;26;115;1348;392;99;2.68;51.85;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2006, 2008-2021;"Drug Discovery (Q1); Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
85;23109;Journal of Psychopharmacology;journal;14617285, 02698811;1.443;Q1;121;176;525;11248;1985;489;3.73;63.91;United Kingdom;Western Europe;SAGE Publications Ltd;1987-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
86;23053;Journal of Natural Products;journal;01633864, 15206025;1.428;Q1;147;330;1210;10465;4324;1187;3.6;31.71;United States;Northern America;American Chemical Society;1949, 1971, 1973, 1978-2021;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
87;19617;Antiviral Research;journal;01663542, 18729096;1.421;Q1;134;171;503;9022;2200;493;4.39;52.76;Netherlands;Western Europe;Elsevier;1959, 1981-2021;"Pharmacology (Q1); Virology (Q2)"
88;23079;Journal of Pharmaceutical Sciences;journal;15206017, 00223549;1.419;Q1;186;430;1305;16753;5087;1256;3.72;38.96;United States;Northern America;"John Wiley &amp; Sons Inc.";1961-2021;Pharmaceutical Science (Q1)
89;12331;Current Topics in Medicinal Chemistry;journal;15680266, 18734294;1.409;Q1;122;233;510;22139;1965;440;3.75;95.02;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
90;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.382;Q1;163;266;675;14800;2774;646;3.88;55.64;United States;Northern America;American Chemical Society;1988-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
91;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;1.372;Q1;153;242;658;8038;2421;517;3.51;33.21;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
92;18966;Mutagenesis;journal;02678357, 14643804;1.353;Q1;95;88;242;4553;942;231;3.76;51.74;United Kingdom;Western Europe;Oxford University Press;1986-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Genetics (Q2); Genetics (clinical) (Q2)"
93;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.347;Q1;96;77;198;2860;621;189;3.15;37.14;United Kingdom;Western Europe;Nature Publishing Group;2006-2021;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
94;20664;Current Drug Targets;journal;18735592, 13894501;1.332;Q1;107;194;483;18772;1863;438;4.18;96.76;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
95;20783;Expert Review of Vaccines;journal;14760584, 17448395;1.331;Q1;91;150;465;8819;1797;378;3.91;58.79;United Kingdom;Western Europe;Taylor and Francis Ltd.;2002-2021;"Drug Discovery (Q1); Pharmacology (Q1); Immunology (Q2); Molecular Medicine (Q2)"
96;21353;Expert Opinion on Therapeutic Patents;journal;13543776, 17447674;1.33;Q1;77;100;339;7922;1227;333;3.45;79.22;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
97;26512;Tetrahedron;journal;14645416, 00404020;1.329;Q1;226;1255;3673;64433;11656;3649;3.1;51.34;United Kingdom;Western Europe;Elsevier Ltd.;1957-2021;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
98;21790;Antiviral Therapy;journal;20402058, 13596535;1.303;Q1;89;183;436;7095;1456;425;3.29;38.77;United Kingdom;Western Europe;International Medical Press Ltd;1996-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
99;25219;Toxicology;journal;0300483X, 18793185;1.303;Q1;165;189;683;9393;2982;656;4.52;49.7;Ireland;Western Europe;Elsevier Ireland Ltd;1959, 1973-2021;Toxicology (Q1)
100;24763;Addictive Behaviors;journal;03064603;1.282;Q1;135;230;613;9581;1622;612;2.39;41.66;United Kingdom;Western Europe;Elsevier Ltd.;1975-2022;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
101;20682;Current Pharmaceutical Design;journal;13816128, 18734286;1.28;Q1;166;585;1163;65504;4773;1058;3.73;111.97;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1995-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
102;21331;European Journal of Pharmaceutical Sciences;journal;18790720, 09280987;1.271;Q1;144;255;567;10045;2283;559;3.48;39.39;Netherlands;Western Europe;Elsevier;1993-2021;Pharmaceutical Science (Q1)
103;20049;Behavioural Pharmacology;journal;14735849, 09558810;1.269;Q1;83;85;261;4860;775;258;2.42;57.18;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1992-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
104;20680;Current Opinion in Molecular Therapeutics;journal;14648431;1.262;Q1;66;0;165;0;644;159;3.89;0;United Kingdom;Western Europe;Current Drugs Ltd.;1999-2010;"Drug Discovery (Q1); Pharmacology (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
105;13250;Expert Opinion on Biological Therapy;journal;14712598, 17447682;1.247;Q1;91;183;429;11683;1783;425;4.15;63.84;United Kingdom;Western Europe;Taylor and Francis Ltd.;2001-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
106;24604;Archives of Toxicology;journal;14320738, 03405761;1.233;Q1;121;179;378;9157;1822;331;5.74;51.16;Germany;Western Europe;Springer Verlag;1930-1940, 1943-1944, 1972-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
107;130044;Pharmacogenetics and Genomics;journal;17446880, 17446872;1.23;-;144;98;324;4023;1377;322;3.92;41.05;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2005-2021;"Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
108;25075;Ecotoxicology;journal;09639292, 15733017;1.218;Q1;97;226;496;11311;1465;493;3.04;50.05;Netherlands;Western Europe;Springer Netherlands;1992-2021;"Health, Toxicology and Mutagenesis (Q1); Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
109;18071;Neurotoxicity Research;journal;14763524, 10298428;1.217;Q1;78;68;245;5163;868;241;3.22;75.93;United States;Northern America;Springer New York;1999, 2001-2021;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
110;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;1.204;Q1;171;743;2565;28934;8856;2554;3.25;38.94;United Kingdom;Western Europe;Elsevier Ltd.;1993-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
111;17464;European Journal of Medicinal Chemistry;journal;02235234, 17683254;1.204;Q1;175;609;2060;23712;8898;2059;3.99;38.94;France;Western Europe;Elsevier Masson s.r.l.;1974-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Organic Chemistry (Q1); Pharmacology (Q1)"
112;14500154702;Journal of Cardiovascular Translational Research;journal;19375395, 19375387;1.198;Q1;53;84;239;5662;701;224;3.4;67.4;United States;Northern America;Springer New York;2008-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmaceutical Science (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Medicine (Q2)"
113;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085, 1873264X;1.198;Q1;133;446;1322;12703;4572;1310;3.45;28.48;Netherlands;Western Europe;Elsevier;1983-2022;"Analytical Chemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Spectroscopy (Q1)"
114;24028;Reproductive Toxicology;journal;08906238, 18731708;1.198;Q1;117;156;395;7631;1455;366;3.26;48.92;United States;Northern America;Elsevier Inc.;1987-2021;Toxicology (Q1)
115;21197;Pharmacology Biochemistry and Behavior;journal;00913057, 18735177;1.197;Q1;139;273;759;17137;2317;756;2.88;62.77;United States;Northern America;Elsevier Inc.;1973-2021;"Clinical Biochemistry (Q1); Pharmacology (Q1); Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Biological Psychiatry (Q2)"
116;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;1.196;Q1;71;65;201;2405;617;168;2.74;37;Netherlands;Western Europe;Kluwer Academic Publishers;1987-2021;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
117;21100370879;"Journal of managed care &amp; specialty pharmacy";journal;23761032, 23760540;1.177;Q1;66;74;223;1730;540;141;2.02;23.38;United States;Northern America;Academy of Managed Care Pharmacy (AMCP);2014-2021;"Health Policy (Q1); Pharmaceutical Science (Q1); Pharmacy (Q1)"
118;19700175004;Open Medicinal Chemistry Journal;journal;18741045;1.174;Q1;18;4;20;140;81;18;4.26;35;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2009-2020;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
119;16088;Journal of Nanobiotechnology;journal;14773155;1.169;Q1;84;45;101;1810;465;101;4.64;40.22;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2021;"Applied Microbiology and Biotechnology (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2)"
120;23015;Journal of Ethnopharmacology;journal;03788741, 18727573;1.157;Q1;205;660;1767;28827;6882;1760;3.47;43.68;Ireland;Western Europe;Elsevier Ireland Ltd;1979-2022;"Drug Discovery (Q1); Pharmacology (Q1)"
121;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;1.154;Q1;81;82;379;3570;1146;374;2.85;43.54;Poland;Eastern Europe;Polish Physiological Society;1991-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q2)"
122;24786;Alcohol and Alcoholism;journal;07350414, 14643502;1.146;Q1;103;116;307;4396;889;272;2.05;37.9;United Kingdom;Western Europe;Oxford University Press;1965-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
123;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.145;Q1;129;115;339;5042;801;328;1.96;43.84;United States;Northern America;Alcohol Research Documentation, Inc.;2007-2021;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
124;4400151608;ChemMedChem;journal;18607187, 18607179;1.142;Q1;106;215;664;10563;2069;642;2.98;49.13;United Kingdom;Western Europe;John Wiley and Sons Ltd;2006-2021;"Organic Chemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q2)"
125;20663;Current Drug Metabolism;journal;18755453, 13892002;1.139;Q1;111;131;261;14321;1297;232;4.47;109.32;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Pharmacology (Q1); Clinical Biochemistry (Q2)"
126;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412703, 19412711;1.129;Q1;73;46;122;1940;386;112;3.42;42.17;United States;Northern America;Mary Ann Liebert Inc.;2008-2021;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q1); Pulmonary and Respiratory Medicine (Q1)"
127;25096;Food and Chemical Toxicology;journal;18736351, 02786915;1.126;Q1;183;703;1482;28189;5913;1454;3.64;40.1;United Kingdom;Western Europe;Elsevier Ltd.;1982-2021;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
128;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863, 2162660X;1.12;Q1;76;12;34;2387;150;34;3.32;198.92;United States;Northern America;Begell House Inc.;1984-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
129;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;1.116;Q1;78;43;143;1575;462;133;3.07;36.63;Switzerland;Western Europe;S. Karger AG;1988-1997, 2004-2021;"Dermatology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q2)"
130;22983;Journal of Clinical Pharmacology;journal;15524604, 00912700;1.111;Q1;121;217;485;5681;1502;467;2.88;26.18;United States;Northern America;Wiley-Blackwell;1973-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
131;21455;Progress in Medicinal Chemistry;journal;00796468, 18757863;1.11;Q1;36;5;26;518;58;12;2.25;103.6;Netherlands;Western Europe;Elsevier;1961-1963, 1965, 1967, 1969-2021;"Pharmacology (Q1); Molecular Medicine (Q2)"
132;20051;BioDrugs;journal;11738804, 1179190X;1.106;Q1;71;42;130;3053;541;127;3.58;72.69;United Kingdom;Western Europe;Adis International Ltd;1997-2021;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
133;22378;Vascular Pharmacology;journal;18793649, 15371891;1.106;Q1;100;68;189;4369;596;182;3.43;64.25;United States;Northern America;Elsevier Inc.;2002-2021;"Pharmacology (Q1); Molecular Medicine (Q2); Physiology (Q2)"
134;22477;Investigational New Drugs;journal;01676997, 15730646;1.1;Q1;90;273;356;8820;1130;354;3.28;32.31;Netherlands;Western Europe;Kluwer Academic Publishers;1983-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Oncology (Q2)"
135;24652;Chemico-Biological Interactions;journal;00092797;1.099;Q1;128;98;854;4662;3116;828;3.47;47.57;Ireland;Western Europe;Elsevier Ireland Ltd;1969-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
136;26514;Tetrahedron Letters;journal;00404039, 18733581;1.094;Q1;173;1666;5333;58001;14370;5330;2.67;34.81;United Kingdom;Western Europe;Elsevier Ltd.;1959-2021;"Drug Discovery (Q1); Biochemistry (Q2); Organic Chemistry (Q2)"
137;19700176055;F1000 Biology Reports;journal;1757594X, 17404118;1.093;Q1;31;24;114;1414;245;113;2.15;58.92;United Kingdom;Western Europe;Faculty of 1000 Ltd;2010-2013;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Immunology and Microbiology (miscellaneous)  (Q2); Neuroscience (miscellaneous) (Q2)"
138;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;1.091;Q1;154;1482;4589;39955;12246;4586;2.57;26.96;United Kingdom;Western Europe;Elsevier Ltd.;1991-2021;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Molecular Medicine (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
139;17067;Phytomedicine;journal;09447113, 1618095X;1.09;Q1;127;188;552;6276;2148;543;3.71;33.38;Germany;Western Europe;Urban und Fischer Verlag Jena;1994-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
140;19700175230;Drug Design, Development and Therapy;journal;11778881;1.089;Q1;71;43;93;1938;432;93;5.18;45.07;New Zealand;Pacific Region;Dove Medical Press Ltd.;2007-2021;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
141;19700174918;Clinical and Translational Science;journal;17528062, 17528054;1.086;Q1;48;78;301;1952;462;186;1.75;25.03;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Neuroscience (miscellaneous) (Q2)"
142;5800173385;Recent Patents on Anti-Cancer Drug Discovery;journal;15748928;1.082;Q1;46;24;80;3030;254;77;2.98;126.25;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2)"
143;29097;Cancer Chemotherapy and Pharmacology;journal;14320843, 03445704;1.081;Q1;114;285;900;8681;2880;878;3.18;30.46;Germany;Western Europe;Springer Verlag;1978-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2)"
144;18075;Neurotoxicology and Teratology;journal;08920362, 18729738;1.081;Q1;103;67;213;3981;697;201;3.48;59.42;United States;Northern America;Elsevier Inc.;1987-2021;"Toxicology (Q1); Developmental Neuroscience (Q2); Cellular and Molecular Neuroscience (Q3)"
145;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;1.081;Q1;76;53;153;3056;423;149;2.61;57.66;United States;Northern America;Elsevier Inc.;1996, 1998-2021;"Pharmacology (Q1); Biochemistry (Q2); Physiology (Q2); Cell Biology (Q3)"
146;9000153111;Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology;journal;15320456, 18781659;1.077;Q1;113;104;387;5514;1151;382;2.82;53.02;United States;Northern America;Elsevier Inc.;1989, 2000-2022;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1); Biochemistry (Q2); Physiology (Q2); Cell Biology (Q3)"
147;25240;Toxicology Letters;journal;03784274, 18793169;1.072;Q2;150;332;892;14185;3319;869;3.38;42.73;Netherlands;Western Europe;Elsevier BV;1977-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
148;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;1.068;Q1;104;145;501;6055;1467;477;2.66;41.76;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1)"
149;19700174974;Future Medicinal Chemistry;journal;17568919, 17568927;1.047;Q1;76;191;426;13920;1081;338;2.57;72.88;United Kingdom;Western Europe;Future Science;2009-2021;"Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
150;19700194010;MedChemComm;journal;20402503, 20402511;1.042;Q1;0;0;0;0;0;0;0;0;United Kingdom;Western Europe;Royal Society of Chemistry;2010-2019;"Pharmaceutical Science (Q1); Biochemistry (Q2)"
151;7700153108;International Journal of Nanomedicine;journal;11782013, 11769114;1.041;Q1;145;519;480;22168;2066;480;4.12;42.71;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Bioengineering (Q2); Biomaterials (Q2); Biophysics (Q2); Nanoscience and Nanotechnology (Q2); Organic Chemistry (Q2)"
152;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;1.036;Q2;114;213;539;6510;1630;450;2.71;30.56;Germany;Western Europe;Springer Verlag;1968-2021;"Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2)"
153;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;1.033;Q1;104;129;258;4756;860;246;3.13;36.87;Netherlands;Western Europe;Springer Netherlands;1987-2021;"Computer Science Applications (Q1); Drug Discovery (Q1); Physical and Theoretical Chemistry (Q2)"
154;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;1.027;Q2;100;121;293;11637;969;261;3;96.17;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Cancer Research (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
155;23014;Journal of Drug Targeting;journal;10292330, 1061186X;1.025;Q1;95;82;266;5121;885;259;3.38;62.45;United Kingdom;Western Europe;Informa Healthcare;1986-1987, 1992-2021;Pharmaceutical Science (Q1)
156;22319;Toxicon;journal;18793150, 00410101;1.019;Q2;133;229;816;10969;2582;795;3.21;47.9;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;Toxicology (Q2)
157;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;1.011;Q2;115;132;494;6180;1183;494;2.37;46.82;United States;Northern America;Springer New York;1973-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q2)"
158;11900154314;Cardiovascular Therapeutics;journal;17555914, 17555922;1.009;Q2;48;74;153;4591;431;143;2.75;62.04;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2)"
159;15581;Current Pharmaceutical Biotechnology;journal;13892010, 18734316;1.008;Q1;88;269;421;24520;1329;384;2.8;91.15;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Biotechnology (Q1); Pharmaceutical Science (Q1)"
160;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484, 19404034;0.99;Q2;52;53;140;1992;352;137;2.69;37.58;United Kingdom;Western Europe;SAGE Publications Ltd;1996-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2)"
161;21333;European Journal of Pharmacology;journal;00142999, 18790712;0.989;Q2;189;537;2090;22179;6684;2086;3.04;41.3;Netherlands;Western Europe;Elsevier;1967-2021;Pharmacology (Q2)
162;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0.982;Q2;64;53;113;1610;255;110;2.04;30.38;United States;Northern America;Springer New York;1996-1999, 2001-2021;Pharmacology (Q2)
163;18073;NeuroToxicology;journal;18729711, 0161813X;0.982;Q2;122;183;387;10849;1261;375;2.79;59.28;Netherlands;Western Europe;Elsevier;1979-2021;"Neuroscience (miscellaneous) (Q2); Toxicology (Q2)"
164;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;0.981;Q2;87;154;541;5577;1379;540;2.47;36.21;Japan;Asiatic Region;Japanese Pharmacological Society;1996-2021;"Molecular Medicine (Q2); Pharmacology (Q2)"
165;29712;Clinical Therapeutics;journal;1879114X, 01492918;0.976;Q2;140;209;765;7394;2078;682;2.35;35.38;United States;Northern America;Elsevier Inc.;1977-2021;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
166;23155;Current Vascular Pharmacology;journal;15701611, 18756212;0.975;Q2;63;107;217;8016;734;205;3.11;74.92;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2003-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q2)"
167;4100151708;Inflammation and Allergy - Drug Targets;journal;18715281;0.973;Q2;51;66;153;4860;535;140;2.64;73.64;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2015;"Medicine (miscellaneous) (Q1); Immunology (Q2); Immunology and Allergy (Q2); Pharmacology (Q2)"
168;21167;Pharmacogenomics;journal;14622416, 17448042;0.968;Q2;94;207;538;8718;1837;450;3.43;42.12;United Kingdom;Western Europe;Future Medicine Ltd.;2000-2021;"Molecular Medicine (Q2); Pharmacology (Q2); Genetics (Q3)"
169;17595;Journal of Biomolecular Screening;journal;10870571, 1552454X;0.964;Q1;79;139;378;4208;944;373;2.43;30.27;United States;Northern America;SAGE Publications Inc.;1996-2017;"Drug Discovery (Q1); Analytical Chemistry (Q2); Biochemistry (Q2); Biotechnology (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
170;19034;Microbial Drug Resistance;journal;10766294, 19318448;0.963;Q2;72;86;180;2916;493;180;2.84;33.91;United States;Northern America;Mary Ann Liebert Inc.;1995-2021;"Medicine (miscellaneous) (Q1); Immunology (Q2); Microbiology (Q2); Microbiology (medical) (Q2); Pharmacology (Q2)"
171;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.951;Q2;90;123;304;4877;668;301;2.14;39.65;United States;Northern America;Springer New York;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Environmental Science (miscellaneous) (Q1); Mathematics (miscellaneous) (Q1); Computational Theory and Mathematics (Q2); Immunology (Q2); Neuroscience (miscellaneous) (Q2); Pharmacology (Q2)"
172;24785;Alcohol;journal;07418329;0.949;Q2;83;84;216;4807;590;213;2.61;57.23;United States;Northern America;Elsevier Inc.;1984-2021;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Biochemistry (Q2); Neurology (Q2); Toxicology (Q2); Behavioral Neuroscience (Q3)"
173;4700152856;Expert Opinion on Drug Metabolism and Toxicology;journal;17425255;0.942;Q2;88;127;366;10730;1380;363;3.57;84.49;United Kingdom;Western Europe;Taylor and Francis Ltd.;2005-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Toxicology (Q2)"
174;24797;Mini-Reviews in Medicinal Chemistry;journal;18755607, 13895575;0.941;Q1;95;140;364;12246;1246;356;3.38;87.47;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
175;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.936;Q2;96;136;391;5235;1224;383;2.8;38.49;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1990-2021;"Pharmacology (medical) (Q1); Oncology (Q2); Pharmacology (Q2); Cancer Research (Q3)"
176;13248;Experimental and Toxicologic Pathology;journal;09402993, 16181433;0.925;Q2;70;130;232;5257;677;229;2.64;40.44;Germany;Western Europe;Urban und Fischer Verlag Jena;1992-2017;"Medicine (miscellaneous) (Q1); Pathology and Forensic Medicine (Q1); Toxicology (Q2); Cell Biology (Q3)"
177;25224;Toxicology in Vitro;journal;18793177, 08872333;0.924;Q2;112;164;752;6781;2546;744;3.14;41.35;United Kingdom;Western Europe;Elsevier Ltd.;1987-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
178;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;0.92;Q2;70;51;120;2221;351;117;2.56;43.55;United States;Northern America;Mary Ann Liebert Inc.;2011-2021;"Biochemistry (Q2); Drug Discovery (Q2); Genetics (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
179;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0.918;Q2;52;49;153;1826;399;144;2.15;37.27;United States;Northern America;Wiley-Liss Inc.;2003-2016;"Embryology (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Developmental Biology (Q3)"
180;4700151615;Scandinavian Journal of Work, Environment and Health, Supplement;journal;03566528;0.917;Q2;23;0;14;0;29;6;0;0;Finland;Western Europe;Finnish Institute of Occupational Health;2005-2011, 2016-2018;"Geography, Planning and Development (Q1); Public Health, Environmental and Occupational Health (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
181;4400151410;Human Vaccines;journal;15548600, 15548619;0.916;Q1;58;0;598;0;1435;442;2.39;0;United States;Northern America;Landes Bioscience;2005-2011;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Immunology (Q2)"
182;18500157900;Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment;journal;19440057, 19440049;0.906;Q2;80;199;535;6544;1348;525;2.49;32.88;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Medicine (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
183;20473;Life Sciences;journal;18790631, 00243205;0.906;Q1;174;338;773;14186;2301;769;2.96;41.97;United States;Northern America;Elsevier Inc.;1962-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
184;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0.898;Q2;51;44;137;4301;467;137;3.04;97.75;United Kingdom;Western Europe;Taylor and Francis Ltd.;2000-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
185;14805;Steroids;journal;0039128X, 18785867;0.898;Q2;107;201;511;8821;1558;506;3.07;43.89;United States;Northern America;Elsevier Inc.;1963-2021;"Biochemistry (Q2); Clinical Biochemistry (Q2); Endocrinology (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Biology (Q3)"
186;144790;Marine Drugs;journal;16603397;0.897;Q2;128;195;377;8688;1774;376;4.85;44.55;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2003-2021;Drug Discovery (Q2)
187;144956;Drug Metabolism and Pharmacokinetics;journal;13474367;0.896;Q1;69;80;226;3346;604;193;2.19;41.83;Japan;Asiatic Region;Japanese Society for the Study of Xenobiotics;2002-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
188;22432;International Immunopharmacology;journal;18781705, 15675769;0.892;Q2;119;270;780;10672;2359;762;2.79;39.53;Netherlands;Western Europe;Elsevier;2001-2021;"Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
189;25109;Inhalation Toxicology;journal;08958378, 10917691;0.889;Q2;90;96;393;4245;987;386;2.26;44.22;United Kingdom;Western Europe;Informa Healthcare;1989-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
190;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.886;Q2;75;52;211;1798;474;205;2.21;34.58;United States;Northern America;Elsevier Inc.;1992-2002, 2004-2021;"Pharmacology (Q2); Toxicology (Q2)"
191;25125;Journal of Analytical Toxicology;journal;19452403, 01464760;0.881;Q2;78;97;291;2112;617;274;2.45;21.77;United States;Northern America;Preston Publications;1977-2021;"Chemical Health and Safety (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
192;15840;Journal of Antibiotics;journal;00218820, 18811469;0.877;Q2;84;120;388;2793;842;366;2.35;23.28;United Kingdom;Western Europe;Japan Antibiotics Research Association;1953-2021;"Drug Discovery (Q2); Pharmacology (Q2)"
193;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298, 14321912;0.876;Q2;93;116;336;5510;836;336;2.31;47.5;Germany;Western Europe;Springer Verlag;1969-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
194;25214;Toxicologic Pathology;journal;15331601, 01926233;0.874;Q2;112;116;341;5559;822;309;2.24;47.92;United States;Northern America;SAGE Publications Inc.;1972-2021;"Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q3)"
195;16836;BMC Chemical Biology;journal;14726769;0.86;Q2;20;5;16;189;46;16;3.11;37.8;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Drug Discovery (Q2); Molecular Medicine (Q3)"
196;29053;Molecular Diversity;journal;1573501X, 13811991;0.852;Q2;58;76;234;2527;777;225;3.09;33.25;Netherlands;Western Europe;Springer Netherlands;1995-1998, 2000, 2003-2021;"Information Systems (Q1); Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Inorganic Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Catalysis (Q3); Molecular Biology (Q3)"
197;18922;Journal of Gene Medicine;journal;1099498X, 15212254;0.841;Q2;94;69;274;3001;741;263;2.41;43.49;United States;Northern America;John Wiley and Sons Ltd;1998-2021;"Drug Discovery (Q2); Genetics (Q3); Genetics (clinical) (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
198;130063;Pharmacological Reports;journal;17341140;0.838;Q2;87;161;432;6871;1219;418;2.43;42.68;Netherlands;Western Europe;Elsevier BV;2005-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
199;4000150314;Chemical Biology and Drug Design;journal;17470277;0.837;-;82;218;442;8263;1192;425;2.7;37.9;United Kingdom;Western Europe;Blackwell;2006-2021;"Biochemistry (Q2); Molecular Medicine (Q3)"
200;19984;Assay and Drug Development Technologies;journal;1540658X, 15578127;0.834;Q2;58;89;262;1729;307;151;1.03;19.43;United States;Northern America;Mary Ann Liebert Inc.;2002-2021;"Drug Discovery (Q2); Molecular Medicine (Q3)"
201;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;0.833;Q2;98;191;610;8040;1536;601;2.31;42.09;United Kingdom;Western Europe;Nature Publishing Group;1980-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
202;25093;Environmental Toxicology;journal;15227278, 15204081;0.83;Q2;81;79;215;3426;532;214;2.48;43.37;United States;Northern America;"John Wiley &amp; Sons Inc.";1980, 1999-2021;"Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
203;4700152848;PPAR Research;journal;16874757, 16874765;0.83;Q2;52;86;117;5992;311;110;2.88;69.67;United States;Northern America;Hindawi Publishing Corporation;2006-2021;"Drug Discovery (Q2); Pharmacology (medical) (Q2)"
204;11300153402;Biomarkers in Medicine;journal;17520363, 17520371;0.826;Q2;49;92;251;4922;591;209;2.69;53.5;United Kingdom;Western Europe;Future Medicine Ltd.;2008-2021;"Biochemistry (medical) (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2)"
205;21273;Journal of Immune Based Therapies and Vaccines;journal;14768518;0.826;Q2;21;0;21;0;51;21;2.56;0;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2011;"Pharmacology (Q2); Immunology (Q3)"
206;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.819;Q2;96;130;331;5643;971;320;2.66;43.41;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
207;6400153120;Chinese Medicine;journal;17498546;0.813;Q2;45;28;108;951;366;100;3.43;33.96;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2021;"Complementary and Alternative Medicine (Q1); Pharmacology (Q2)"
208;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.81;Q2;91;107;274;5512;807;271;2.7;51.51;United Kingdom;Western Europe;John Wiley and Sons Ltd;1981-2021;Toxicology (Q2)
209;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.81;Q2;112;164;421;7352;1167;394;2.61;44.83;United States;Northern America;Academic Press Inc.;1970, 1981-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
210;21229;Drug News and Perspectives;journal;02140934;0.808;Q2;51;0;143;0;311;139;2.75;0;Spain;Western Europe;Prous Science;1990-2010;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
211;16573;Phytotherapy Research;journal;10991573, 0951418X;0.807;Q2;140;304;925;9571;2697;924;2.62;31.48;United Kingdom;Western Europe;John Wiley and Sons Ltd;1987-2021;Pharmacology (Q2)
212;19700174958;Drug Testing and Analysis;journal;19427611, 19427603;0.806;Q1;57;150;278;4689;732;255;2.97;31.26;United Kingdom;Western Europe;John Wiley and Sons Ltd;2009-2021;"Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2); Spectroscopy (Q2)"
213;22410;Inflammation Research;journal;1420908X, 10233830;0.806;Q2;94;157;443;6226;986;440;2.12;39.66;Switzerland;Western Europe;Birkhauser Verlag Basel;1995-2021;"Pharmacology (Q2); Immunology (Q3)"
214;19374;AAPS PharmSciTech;journal;15309932;0.804;Q1;101;164;529;5176;1259;529;2.16;31.56;Switzerland;Western Europe;Springer International Publishing AG;2000-2021;"Agronomy and Crop Science (Q1); Pharmaceutical Science (Q1); Aquatic Science (Q2); Drug Discovery (Q2); Ecology (Q2); Ecology, Evolution, Behavior and Systematics (Q2); Medicine (miscellaneous) (Q2)"
215;130025;Current Drug Delivery;journal;15672018;0.804;Q1;65;64;183;3473;489;179;2.92;54.27;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Pharmaceutical Science (Q1)
216;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.804;Q2;90;165;497;6188;991;496;1.92;37.5;United States;Northern America;Informa Healthcare;1974, 1976-2021;"Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
217;5800173402;Recent Patents on CNS Drug Discovery;journal;15748898;0.803;Q2;34;25;58;3322;178;58;3;132.88;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2016;"Drug Discovery (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2)"
218;130047;Current Drug Discovery Technologies;journal;15701638;0.801;Q2;44;34;94;2615;283;87;2.42;76.91;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Drug Discovery (Q2)
219;20602;Clinical Neuropharmacology;journal;1537162X, 03625664;0.8;Q2;80;63;234;1632;604;208;2.5;25.9;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1982-2021;"Neurology (clinical) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
220;14990;Current Neuropharmacology;journal;18756190, 1570159X;0.799;Q2;82;35;170;4661;492;162;2.28;133.17;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;"Medicine (miscellaneous) (Q2); Neurology (Q2); Neurology (clinical) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2)"
221;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;0.793;Q2;52;81;246;1510;261;221;0.81;18.64;United States;Northern America;Taylor and Francis Ltd.;1991-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Statistics and Probability (Q2)"
222;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.793;Q1;81;46;127;2461;351;124;2.7;53.5;Canada;Northern America;Canadian Society for Pharmaceutical Sciences;1998-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
223;26370;Molecules;journal;14203049;0.792;Q1;171;1056;1811;41682;5797;1809;2.91;39.47;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);1992, 1996-2021;"Chemistry (miscellaneous) (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Molecular Medicine (Q3)"
224;18077;Fitoterapia;journal;0367326X, 18736971;0.791;Q2;110;253;535;7559;1587;533;2.92;29.88;Netherlands;Western Europe;Elsevier;1948-1949, 1961, 1972-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
225;26767;Altex;journal;1868596X, 18688551;0.79;Q2;57;36;93;1481;289;78;3.47;41.14;Germany;Western Europe;Springer International Publishing AG;2000-2021;"Medical Laboratory Technology (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
226;19700174913;Therapeutic Advances in Neurological Disorders;journal;17562864, 17562856;0.789;Q2;56;28;93;1970;299;89;4;70.36;United Kingdom;Western Europe;SAGE Publications Ltd;2008-2021;"Neurology (Q2); Neurology (clinical) (Q2); Pharmacology (Q2)"
227;14487;Journal of Ocular Pharmacology and Therapeutics;journal;15577732, 10807683;0.785;Q2;64;109;280;2867;563;272;1.88;26.3;United States;Northern America;Mary Ann Liebert Inc.;1987, 1991-1993, 1995-2021;"Ophthalmology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
228;16533;Phytochemical Analysis;journal;09580344, 10991565;0.784;Q2;76;96;220;2359;585;216;2.81;24.57;United Kingdom;Western Europe;John Wiley and Sons Ltd;1990-2021;"Complementary and Alternative Medicine (Q1); Food Science (Q1); Analytical Chemistry (Q2); Biochemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Plant Science (Q2); Molecular Medicine (Q3)"
229;11500153306;Recent Patents on Drug Delivery and Formulation;journal;22124039, 18722113;0.783;Q1;36;22;55;2367;179;54;2.5;107.59;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2020;"Pharmaceutical Science (Q1); Biomedical Engineering (Q2); Medicine (miscellaneous) (Q2)"
230;6800153101;Expert Opinion on Drug Discovery;journal;1746045X, 17460441;0.782;Q2;68;90;274;8586;625;273;2.42;95.4;United Kingdom;Western Europe;Informa Healthcare;2006-2021;Drug Discovery (Q2)
231;25898;Journal of Peptide Science;journal;10752617, 10991387;0.78;Q2;68;101;326;3701;680;319;2.12;36.64;United Kingdom;Western Europe;John Wiley and Sons Ltd;1995-2021;"Biochemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Biology (Q3); Molecular Medicine (Q3); Structural Biology (Q3)"
232;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0.779;Q2;107;153;550;7366;1204;508;2.2;48.14;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q2); Physiology (medical) (Q2); Physiology (Q3)"
233;4000148406;Clinical Toxicology;journal;15569519, 15563650;0.776;Q2;98;145;456;2930;1191;377;2.51;20.21;United Kingdom;Western Europe;Informa Healthcare;1968-1998, 2005-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
234;18200156702;World Mycotoxin Journal;journal;18750710, 18750796;0.774;Q2;40;44;127;1846;305;122;2.65;41.95;Netherlands;Western Europe;Wageningen Academic Publishers;2009-2021;"Food Science (Q1); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
235;5800228222;Journal of Pharmaceutical Innovation;journal;18725120, 19398042;0.762;Q1;31;22;68;570;102;61;1.73;25.91;United States;Northern America;Springer New York;2006-2021;"Pharmaceutical Science (Q1); Drug Discovery (Q2)"
236;21124;Pharmaceutical Statistics;journal;15391612, 15391604;0.76;Q2;39;65;144;1136;187;134;1.19;17.48;United Kingdom;Western Europe;John Wiley and Sons Ltd;2004-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Statistics and Probability (Q2)"
237;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785, 15578852;0.756;Q2;63;93;267;3431;591;256;2.01;36.89;United States;Northern America;Mary Ann Liebert Inc.;1996-2021;"Medicine (miscellaneous) (Q2); Oncology (Q2); Pharmacology (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3)"
238;21352;Expert Opinion on Pharmacotherapy;journal;17447666, 14656566;0.756;Q2;83;251;812;16233;2208;780;2.67;64.67;United Kingdom;Western Europe;Taylor and Francis Ltd.;1999-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
239;19700182043;Drug Delivery and Translational Research;journal;21903948, 2190393X;0.755;Q1;46;39;46;2240;105;40;2.28;57.44;United States;Northern America;Springer Publishing Company;2011-2021;Pharmaceutical Science (Q1)
240;23942;Biomedical Chromatography;journal;10990801, 02693879;0.752;Q2;68;220;525;5504;1144;514;2.16;25.02;United Kingdom;Western Europe;John Wiley and Sons Ltd;1986-2021;"Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
241;24578;Mathematical Medicine and Biology;journal;14778599;0.752;Q2;46;21;50;741;116;49;2;35.29;United Kingdom;Western Europe;Oxford University Press;1984-2021;"Applied Mathematics (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Environmental Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Modeling and Simulation (Q2); Pharmacology (Q2); Immunology and Microbiology (miscellaneous)  (Q3); Neuroscience (miscellaneous) (Q3)"
242;21744;Planta Medica;journal;14390221, 00320943;0.749;Q1;122;251;818;7697;2229;803;2.64;30.67;Germany;Western Europe;Georg Thieme Verlag;1961, 1965-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
243;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.739;Q2;64;34;129;1713;380;128;2.66;50.38;Netherlands;Western Europe;Springer Netherlands;1984-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Cell Biology (Q3)"
244;23039;Journal of Liposome Research;journal;08982104, 15322394;0.736;Q1;53;35;115;1433;258;113;2.14;40.94;United Kingdom;Western Europe;Informa Healthcare;1988-1990, 1992-2021;Pharmaceutical Science (Q1)
245;20570;Chemotherapy;journal;00093157, 14219794;0.735;Q2;58;61;186;2084;444;181;2.5;34.16;Switzerland;Western Europe;S. Karger AG;1960-2021;"Drug Discovery (Q2); Infectious Diseases (Q2); Medicine (miscellaneous) (Q2); Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
246;16803;Antiviral Chemistry and Chemotherapy;journal;20402066, 09563202;0.734;Q2;54;23;57;1092;125;54;1.9;47.48;United Kingdom;Western Europe;SAGE Publications Inc.;1991-2015, 2017-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Virology (Q3)"
247;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.731;Q1;122;346;1076;11073;2542;1053;2.18;32;Japan;Asiatic Region;Pharmaceutical Society of Japan;1993-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
248;19700188352;Toxins;journal;20726651;0.731;Q2;91;89;259;6168;648;257;2.55;69.3;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2009-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
249;4000151703;Core Evidence (discontinued);journal;15551741, 1555175X;0.725;Q2;25;12;38;757;102;36;2.41;63.08;New Zealand;Pacific Region;Dove Medical Press Ltd.;2005-2018;"Reviews and References (medical) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
250;14822;Xenobiotica;journal;00498254, 13665928;0.723;Q2;82;123;294;4392;666;289;2.14;35.71;United Kingdom;Western Europe;Informa Healthcare;1971-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2); Biochemistry (Q3)"
251;21100214102;Frontiers in Pharmacology;journal;16639812;0.717;Q2;104;206;129;17703;311;125;2.41;85.94;Switzerland;Western Europe;Frontiers Media S.A.;2010-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
252;28620;Biomedicine and Pharmacotherapy;journal;07533322;0.713;Q2;109;100;339;3513;839;331;2.45;35.13;France;Western Europe;Elsevier Masson s.r.l.;1982-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
253;25151;Journal of Toxicology and Environmental Health - Part A: Current Issues;journal;10872620, 15287394;0.712;Q2;92;138;472;5417;972;458;1.99;39.25;United Kingdom;Western Europe;Taylor and Francis Ltd.;1996-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
254;19443;American Journal of Health-System Pharmacy;journal;10792082, 15352900;0.7;Q2;99;362;1154;4867;1538;674;1.14;13.44;United States;Northern America;American Society of Health-Systems Pharmacy;1995-2021;"Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
255;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.696;Q1;81;80;242;3301;537;242;2.01;41.26;United Kingdom;Western Europe;Informa Healthcare;1984-2021;"Pharmaceutical Science (Q1); Bioengineering (Q2); Colloid and Surface Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2)"
256;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427843, 17427835;0.691;Q2;93;144;410;5684;990;400;2.38;39.47;United States;Northern America;Wiley-Blackwell;2004-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
257;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.69;Q2;88;170;346;7187;800;344;2.4;42.28;Netherlands;Western Europe;Elsevier;1996-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
258;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.69;Q2;76;131;262;3646;613;255;2.37;27.83;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1976-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
259;19700178100;Nanotechnology, Science and Applications;journal;11778903;0.689;Q1;30;8;27;480;80;27;2.96;60;New Zealand;Pacific Region;Dove Medical Press Limited;2010-2012, 2014-2021;"Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Nanoscience and Nanotechnology (Q2)"
260;19300156901;Dose-Response;journal;15593258;0.688;Q2;41;44;104;1926;248;101;1.95;43.77;United States;Northern America;International Dose-Response Society;2008-2021;"Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
261;24071;Metal-Based Drugs;journal;07930291, 16875486;0.684;Q2;38;0;8;0;27;8;4;0;United States;Northern America;Hindawi Publishing Corporation;1996-2002, 2007-2011;"Drug Discovery (Q2); Inorganic Chemistry (Q2); Pharmacology (Q2); Toxicology (Q2)"
262;5800173387;Reviews on Recent Clinical Trials;journal;15748871;0.683;Q2;32;42;79;2507;186;79;2;59.69;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
263;20770;Drug Delivery;journal;10717544, 15210464;0.68;Q1;72;44;206;1812;433;195;2.24;41.18;United Kingdom;Western Europe;Informa Healthcare;1993, 1995-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2)"
264;22575;Cardiovascular Toxicology;journal;15307905, 15590259;0.679;Q2;56;45;98;1779;258;97;2.75;39.53;United States;Northern America;Humana Press;2001-2021;"Cardiology and Cardiovascular Medicine (Q2); Toxicology (Q2); Molecular Biology (Q3)"
265;19700174632;Journal of Receptor, Ligand and Channel Research;journal;1178699X;0.676;Q2;10;2;10;44;25;9;2.5;22;New Zealand;Pacific Region;Dove Medical Press Ltd.;2010-2016, 2018;"Biophysics (Q2); Pharmacology (Q2); Biochemistry (Q3); Cell Biology (Q3)"
266;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.671;Q1;61;54;142;1771;340;141;2.48;32.8;United Kingdom;Western Europe;John Wiley and Sons Ltd;1979-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
267;23102;Journal of Pharmacy and Pharmacology;journal;20427158, 00223573;0.671;Q1;124;187;578;8313;1481;573;2.43;44.45;United Kingdom;Western Europe;Oxford University Press;1949-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
268;5800173401;Current Bioactive Compounds;journal;15734072;0.66;Q1;27;46;80;2983;120;71;0.81;64.85;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
269;19700174810;International Journal of Pharmacy and Pharmaceutical Sciences (discontinued);journal;09751491;0.66;Q1;49;1106;960;27913;1881;959;1.78;25.24;India;Asiatic Region;IJPPS;2009-2017, 2020-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
270;19700188217;Bioanalysis;journal;17576180, 17576199;0.658;Q1;62;319;599;8909;1227;528;2.02;27.93;United Kingdom;Western Europe;Future Science;2009-2021;"Medical Laboratory Technology (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Analytical Chemistry (Q2); Medicine (miscellaneous) (Q2); Clinical Biochemistry (Q3)"
271;16948;Chirality;journal;1520636X, 08990042;0.656;Q2;80;141;435;5579;1074;432;2.19;39.57;United States;Northern America;Wiley-Liss Inc.;1989-2021;"Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Spectroscopy (Q2); Catalysis (Q3)"
272;19200156706;Pharmacognosy Magazine (discontinued);journal;09731296, 09764062;0.651;Q1;42;56;211;1294;393;203;2.23;23.11;India;Asiatic Region;Wolters Kluwer Medknow Publications;2008-2018, 2020-2021;"Pharmaceutical Science (Q1); Drug Discovery (Q2)"
273;20634;Journal of Texture Studies;journal;00224901, 17454603;0.65;Q1;57;46;144;1574;194;142;1.26;34.22;United States;Northern America;Wiley-Blackwell;1969-2021;"Pharmaceutical Science (Q1); Food Science (Q2)"
274;10900153302;Biomarker Insights;journal;11772719;0.648;Q2;35;16;44;759;108;44;2.47;47.44;New Zealand;Pacific Region;Libertas Academica Ltd.;2008-2021;"Biochemistry (medical) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
275;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.648;Q2;87;173;382;8614;787;374;1.86;49.79;Canada;Northern America;National Research Council of Canada;1964-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3); Physiology (medical) (Q3)"
276;25789;Bioorganic Chemistry;journal;00452068, 10902120;0.638;Q2;66;40;103;1967;194;102;1.79;49.18;United States;Northern America;Academic Press Inc.;1971-2021;"Drug Discovery (Q2); Organic Chemistry (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
277;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.638;Q2;76;439;870;8527;1227;868;1.28;19.42;United States;Northern America;Springer New York;1966-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pollution (Q2); Toxicology (Q2)"
278;21100197941;International Journal for Parasitology: Drugs and Drug Resistance;journal;22113207;0.638;Q2;40;32;4;2137;6;3;1.5;66.78;Netherlands;Western Europe;Elsevier BV;2011-2021;"Infectious Diseases (Q2); Parasitology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
279;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.628;Q2;95;231;895;6333;1628;895;1.78;27.42;Japan;Asiatic Region;Pharmaceutical Society of Japan;1958-2021;"Chemistry (miscellaneous) (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
280;21208;Drug Discovery Today: Therapeutic Strategies;journal;17406773;0.627;Q2;29;27;57;1299;58;49;0.69;48.11;United Kingdom;Western Europe;Elsevier Ltd.;2004-2013;"Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
281;20027;BMC Pharmacology;journal;14712210;0.623;Q2;44;8;49;343;134;49;3.07;42.88;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
282;145524;Drug Discovery Today: Disease Mechanisms;journal;17406765;0.619;Q2;27;9;55;538;79;48;1.54;59.78;United Kingdom;Western Europe;Elsevier Ltd.;2004-2013;"Drug Discovery (Q2); Molecular Medicine (Q3)"
283;17500155003;Records of Natural Products;journal;13076167;0.618;Q2;33;59;101;1484;242;100;2.32;25.15;Turkey;Middle East;ACG Publications;2009-2022;"Drug Discovery (Q2); Pharmacology (Q2); Plant Science (Q2); Organic Chemistry (Q3)"
284;19700175015;Infection and Drug Resistance;journal;11786973;0.614;Q2;44;20;33;953;61;31;2;47.65;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Infectious Diseases (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
285;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073, 18755402;0.607;Q2;66;87;293;4972;630;261;1.99;57.15;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1998-2021;"Computer Science Applications (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q3)"
286;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;0.605;Q2;85;249;804;9032;1236;803;1.53;36.27;United States;Northern America;Wiley-Blackwell;1918-2021;"Drug Discovery (Q2); Inorganic Chemistry (Q2); Biochemistry (Q3); Catalysis (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
287;19700188356;Journal of Excipients and Food Chemicals;journal;21502668;0.603;Q1;16;16;29;570;36;23;1.24;35.63;United States;Northern America;IPEC-Americas;2010-2021;"Pharmaceutical Science (Q1); Food Science (Q2)"
288;5800173383;Current Clinical Pharmacology;journal;15748847, 22123938;0.6;Q1;0;0;0;0;0;0;0;0;United Arab Emirates;Middle East;Bentham Science Publishers;2006-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
289;19700175143;Pharmacognosy Reviews (discontinued);journal;09737847, 09762787;0.596;Q2;54;21;93;1338;194;92;2.48;63.71;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2018;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Pharmacology (Q2); Plant Science (Q2)"
290;21865;Fundamental and Clinical Pharmacology;journal;07673981, 14728206;0.594;Q2;77;84;259;3893;546;252;2.08;46.35;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1987-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
291;21207;Drug Discovery Today: Technologies;journal;17406749;0.593;Q2;53;39;59;1904;98;52;1.72;48.82;United Kingdom;Western Europe;Elsevier Ltd.;2004-2021;"Biotechnology (Q2); Drug Discovery (Q2); Molecular Medicine (Q3)"
292;4600151527;Infectious Disorders - Drug Targets;journal;18715265;0.593;Q2;55;47;145;3616;271;129;1.86;76.94;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q2); Microbiology (medical) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
293;16067;Reading Teacher;journal;00340561;0.591;Q2;53;80;254;1578;197;237;0.49;19.73;United States;Northern America;Wiley-Blackwell;1995-2021;"Linguistics and Language (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
294;19700175819;Patient Preference and Adherence;journal;1177889X;0.59;Q1;54;94;141;3847;266;138;1.96;40.93;New Zealand;Pacific Region;Dove Medical Press Ltd.;2007-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Social Sciences (miscellaneous) (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2)"
295;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.589;Q2;67;146;386;2963;483;350;0.91;20.29;United States;Northern America;American Pharmacists Association;2003-2021;"Pharmacology (nursing) (Q1); Pharmacy (Q1); Pharmacology (Q2)"
296;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.584;Q2;65;104;235;3307;492;235;2.01;31.8;Germany;Western Europe;Wiley-VCH Verlag;1822-1831, 1835-1933, 1937-1938, 1940, 1943-1944, 1950-2021;"Drug Discovery (Q2); Pharmaceutical Science (Q2)"
297;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.582;Q2;62;87;223;2830;332;219;1.57;32.53;United States;Northern America;Informa Healthcare;1996-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
298;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.578;Q3;53;130;335;4145;634;311;1.55;31.88;Japan;Asiatic Region;Japanese Society of Toxicological Sciences;1976-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
299;19700185200;Journal of Natural Medicines;journal;13403443, 18610293;0.574;Q2;50;92;270;2522;517;270;1.83;27.41;Germany;Western Europe;Springer Verlag;2006-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Organic Chemistry (Q3)"
300;19958;Archives of Pharmacal Research;journal;19763786, 02536269;0.572;Q2;93;249;745;8341;1473;722;1.78;33.5;South Korea;Asiatic Region;Pharmaceutical Society of Korea;1978-2021;"Drug Discovery (Q2); Molecular Medicine (Q3); Organic Chemistry (Q3)"
301;19398;Acta Pharmaceutica;journal;18469558, 13300075;0.569;Q2;60;40;120;1196;266;120;1.79;29.9;Croatia;Eastern Europe;Croatian Pharmaceutical Society;1986, 1992-2022;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q2)"
302;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.567;Q2;58;147;545;4495;1117;527;2.15;30.58;Italy;Western Europe;SAGE Publications Inc.;1989-2021;"Pharmacology (Q2); Immunology (Q3); Immunology and Allergy (Q3)"
303;19700175105;Open Drug Delivery Journal;journal;18741266;0.566;Q2;5;0;11;0;11;10;1;0;Netherlands;Western Europe;;;Pharmaceutical Science (Q2)
304;3900148201;International Journal of Pharmacology (discontinued);journal;18125700, 18117775;0.565;Q2;39;98;294;4108;582;291;2.13;41.92;Pakistan;Asiatic Region;Asian Network for Scientific Information;2006-2018, 2020-2021;Pharmacology (Q2)
305;20026;BMC Clinical Pharmacology;journal;14726904;0.564;Q2;39;14;58;469;150;58;2.1;33.5;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
306;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;0.562;Q3;40;47;114;2282;232;110;1.91;48.55;United States;Northern America;Informa Healthcare;2004-2021;"Immunology (Q3); Toxicology (Q3)"
307;4700151922;Research in Social and Administrative Pharmacy;journal;15517411;0.56;Q2;54;58;121;2120;199;104;1.35;36.55;United States;Northern America;Elsevier Inc.;2005-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2)"
308;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.552;Q3;62;71;140;2391;246;139;1.79;33.68;United States;Northern America;"John Wiley &amp; Sons Inc.";1998-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Molecular Medicine (Q3); Toxicology (Q3); Molecular Biology (Q4)"
309;23412;Journal of AOAC International;journal;10603271;0.54;Q2;90;231;703;6760;1020;680;1.35;29.26;United States;Northern America;AOAC International;1993-2021;"Agronomy and Crop Science (Q2); Food Science (Q2); Pharmacology (Q2); Analytical Chemistry (Q3); Environmental Chemistry (Q3)"
310;4200151509;Molecular Diagnosis and Therapy;journal;11771062;0.54;Q2;47;37;109;2509;231;102;1.84;67.81;United Kingdom;Western Europe;Adis International Ltd;2001, 2004, 2006-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
311;21194;Pharmacology;journal;00317012, 14230313;0.54;Q2;60;89;290;2925;540;266;2.06;32.87;Switzerland;Western Europe;S. Karger AG;1959-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
312;17700156714;Pharmaceuticals;journal;14248247;0.539;Q2;69;78;297;5945;500;293;1.7;76.22;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2009-2021;"Pharmaceutical Science (Q2); Molecular Medicine (Q3)"
313;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.535;Q2;62;110;397;3295;443;392;1.39;29.95;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1978-2021;"Pharmacology (Q2); Veterinary (miscellaneous) (Q2)"
314;25171;Mycotoxin Research;journal;18671632, 01787888;0.531;Q3;40;31;99;833;157;98;1.44;26.87;Germany;Western Europe;Springer-Verlag GmbH and Co. KG;1985-2021;"Biotechnology (Q2); Microbiology (Q3); Toxicology (Q3)"
315;19900192900;Molecular Informatics;journal;18681751, 18681743;0.53;Q2;70;75;277;3280;549;268;2.33;43.73;Germany;Western Europe;"Wiley - VCH Verlag GmbH &amp; CO. KGaA";2010-2021;"Computer Science Applications (Q2); Drug Discovery (Q2); Molecular Medicine (Q3); Organic Chemistry (Q3); Structural Biology (Q3)"
316;22411;Inflammopharmacology;journal;09254692, 15685608;0.529;Q3;55;36;98;2083;247;95;1.8;57.86;Switzerland;Western Europe;Birkhauser Verlag Basel;1991-2021;"Pharmacology (medical) (Q2); Immunology (Q3); Pharmacology (Q3)"
317;4700152233;Therapeutics and Clinical Risk Management;journal;11766336;0.516;Q1;59;47;127;2311;277;127;2.19;49.17;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Safety Research (Q1); Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
318;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.515;Q2;46;75;172;1970;303;168;1.64;26.27;Switzerland;Western Europe;MDPI AG;1949, 1960-1961, 1973-2021;Pharmaceutical Science (Q2)
319;4700152609;Current Computer-Aided Drug Design;journal;15734099;0.51;Q2;31;29;76;1626;134;70;1.8;56.07;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
320;11200153306;Journal of Pharmacology and Toxicology (discontinued);journal;1816496X, 2152100X;0.507;Q1;18;43;100;1387;158;100;1.65;32.26;United States;Northern America;Academic Journals Inc.;2008-2017;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
321;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0.502;Q3;40;34;78;3271;168;78;1.96;96.21;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Cardiology and Cardiovascular Medicine (Q2); Medicine (miscellaneous) (Q2); Hematology (Q3); Pharmacology (Q3)"
322;5800173403;Recent Patents on Anti-Infective Drug Discovery;journal;1574891X, 22124071;0.499;Q2;0;0;0;0;0;0;0;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006-2020;"Drug Discovery (Q2); Infectious Diseases (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
323;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.488;Q3;64;41;126;1063;146;110;1.12;25.93;United States;Northern America;Heldref Publications;2005-2021;"Environmental Science (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
324;19700174906;Molecular and Cellular Pharmacology;journal;19381247;0.488;Q2;26;13;80;705;130;68;1.87;54.23;United States;Northern America;Lumitext Publishing;2009-2017, 2020-2021;"Pharmaceutical Science (Q2); Molecular Biology (Q4)"
325;19700174969;Archives of Drug Information;journal;17535174;0.487;Q1;11;0;21;0;39;21;1.64;0;United States;Northern America;"John Wiley &amp; Sons Inc.";2008-2011;"Complementary and Alternative Medicine (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
326;25864;Heterocycles;journal;03855414;0.487;Q3;66;346;1011;12822;1075;1005;1.14;37.06;Japan;Asiatic Region;Japan Institute of Heterocyclic Chemistry;1983-2021;"Analytical Chemistry (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
327;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.479;Q2;74;61;205;2566;384;203;1.62;42.07;United States;Northern America;Wiley-Blackwell;1986-2021;"Applied Microbiology and Biotechnology (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Process Chemistry and Technology (Q2); Bioengineering (Q3); Molecular Medicine (Q3)"
328;4000148204;Pakistan Journal of Pharmaceutical Sciences;journal;1011601X;0.479;Q2;42;131;246;3646;483;246;1.5;27.83;Pakistan;Asiatic Region;Pakistan Journal of Pharmaceutical Sciences;1995, 2005-2021;Pharmaceutical Science (Q2)
329;15300154846;Journal of Occupational Medicine and Toxicology;journal;17456673;0.476;Q3;42;19;101;1232;162;100;1.66;64.84;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2021;"Public Health, Environmental and Occupational Health (Q2); Safety Research (Q2); Toxicology (Q3)"
330;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.474;Q3;62;104;275;4170;469;271;1.64;40.1;United Kingdom;Western Europe;SAGE Publications Ltd;1985-2021;"Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
331;18800156720;Dissolution Technologies;journal;1521298X;0.472;Q2;34;28;85;539;84;80;0.78;19.25;United States;Northern America;Dissolution Technologies Inc;1996-2021;Pharmaceutical Science (Q2)
332;25106;Human and Experimental Toxicology;journal;09603271;0.472;Q3;82;147;459;5456;782;437;1.69;37.12;United States;Northern America;SAGE Publications Inc.;1981-2021;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
333;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.468;Q3;63;101;345;3395;481;319;1.31;33.61;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1960-1961, 1996-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
334;22204;Journal of Drug Delivery Science and Technology;journal;17732247, 25888943;0.468;Q2;52;73;173;3662;195;171;1.38;50.16;France;Western Europe;Editions de Sante;2004-2021;Pharmaceutical Science (Q2)
335;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.462;Q1;69;203;626;3487;782;522;1.12;17.18;United States;Northern America;American Association of Colleges of Pharmacy;1945-1948, 1973-1989, 1991, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Education (Q2); Medicine (miscellaneous) (Q2)"
336;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.461;Q2;42;175;491;2815;563;490;1.09;16.09;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
337;19700174941;Pharmacognosy Research (discontinued);journal;09748490;0.461;Q3;37;39;128;1114;189;119;1.48;28.56;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2019, 2021;"Drug Discovery (Q3); Pharmacology (Q3)"
338;13671;Biologicals;journal;10958320, 10451056;0.46;Q3;60;83;257;2297;502;245;1.95;27.67;United States;Northern America;Academic Press Inc.;1990-2021;"Applied Microbiology and Biotechnology (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Bioengineering (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Pharmacology (Q3)"
339;19400157146;Food Additives and Contaminants: Part B Surveillance;journal;19393210, 19393229;0.459;Q3;32;49;109;1271;136;108;0.93;25.94;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Food Science (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q3)"
340;17700156777;Advances in Pharmacological Sciences;journal;16876342, 16876334;0.455;Q1;38;30;29;1504;63;29;2.36;50.13;United States;Northern America;Hindawi Publishing Corporation;2009-2019;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2); Molecular Medicine (Q3)"
341;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.455;Q2;63;110;304;2948;428;278;1.25;26.8;Netherlands;Western Europe;Springer Netherlands;2011-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3); Toxicology (Q3)"
342;19700175023;Journal of Toxicology;journal;16878205, 16878191;0.454;Q3;39;61;56;3651;118;56;2.11;59.85;Egypt;Africa/Middle East;Hindawi Limited;2010-2021;"Pharmacology (Q3); Toxicology (Q3)"
343;4700152612;Current Nanoscience;journal;15734137;0.453;Q2;47;134;296;4764;501;292;1.52;35.55;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Biomedical Engineering (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3); Nanoscience and Nanotechnology (Q3)"
344;10300153342;Journal of Medical Toxicology;journal;15569039, 19376995;0.453;Q3;52;74;222;1848;332;184;1.6;24.97;United States;Northern America;Springer New York;2005-2021;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
345;17700155034;Natural Product Communications;journal;15559475, 1934578X;0.449;Q3;50;434;1171;10309;1506;1142;1.16;23.75;United States;Northern America;SAGE Publications Inc.;2006-2022;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Plant Science (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
346;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0.448;Q3;79;123;405;4411;597;403;1.38;35.86;United Kingdom;Western Europe;Informa Healthcare;1985-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
347;19700174905;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;journal;11787007;0.447;Q3;50;42;51;2393;84;50;2.24;56.98;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Internal Medicine (Q2); Pharmacology (Q3)"
348;19700174987;Research Journal of Toxins (discontinued);journal;18193560, 21517258;0.445;Q3;3;0;2;0;5;2;0;0;United States;Northern America;Academic Journals Inc.;2009, 2014, 2016;"Agronomy and Crop Science (Q2); Food Science (Q2); Toxicology (Q3)"
349;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.444;Q3;50;40;122;2004;233;121;1.76;50.1;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2021;"Medicine (miscellaneous) (Q2); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
350;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.443;Q3;51;172;474;4990;511;469;1.03;29.01;India;Asiatic Region;Triveni Enterprises;1988-2021;"Environmental Engineering (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
351;19600162009;Advances in Molecular Toxicology;book series;18720854, 22122044;0.442;Q3;15;8;23;1491;37;13;1.67;186.38;Netherlands;Western Europe;Elsevier;2006, 2008-2018, 2020;"Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
352;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.438;Q3;62;66;203;3322;296;192;1.45;50.33;United States;Northern America;SAGE Publications Inc.;1982-2021;Toxicology (Q3)
353;21256;Drugs of Today;journal;00257656, 16993993, 16994019;0.436;Q3;53;75;266;3112;449;264;1.57;41.49;Spain;Western Europe;Prous Science;1968, 1978-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
354;18800156708;Tropical Journal of Pharmaceutical Research;journal;15965996, 15969827;0.436;Q2;39;121;245;2564;335;238;0.97;21.19;Nigeria;Africa;Pharmacotherapy Group;2009-2021;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q2)"
355;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117, 1533869X;0.435;Q3;38;26;64;1153;99;61;1.15;44.35;United States;Northern America;Old City Publishing;1996, 2002-2020;"Cancer Research (Q3); Drug Discovery (Q3); Pharmacology (Q3)"
356;20580;Journal of Food Biochemistry;journal;17454514, 01458884;0.435;Q3;50;87;304;3031;323;298;0.96;34.84;United States;Northern America;Wiley-Blackwell;1977-2021;"Food Science (Q2); Biophysics (Q3); Pharmacology (Q3); Cell Biology (Q4)"
357;11400153335;Recent Patents on Inflammation and Allergy Drug Discovery;journal;1872213X, 22122710;0.434;Q3;29;22;79;2504;139;79;1.46;113.82;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2020;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Immunology and Allergy (Q3)"
358;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.429;Q3;38;41;110;1651;149;109;1.38;40.27;Netherlands;Western Europe;Springer Netherlands;1996-2002, 2005-2021;"Analytical Chemistry (Q3); Biochemistry (Q3); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
359;5800173386;Current Drug Safety;journal;15748863;0.428;Q3;37;63;141;2743;228;129;1.47;43.54;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3); Toxicology (Q3)"
360;23173;Korean Journal of Physiology and Pharmacology;journal;20933827, 12264512;0.427;Q3;33;68;196;2441;239;196;1.18;35.9;South Korea;Asiatic Region;Korean Physiological Soc. and Korean Soc. of Pharmacology;1997-2021;"Pharmacology (Q3); Physiology (Q4)"
361;19700188360;Pharmaceutics;journal;19994923;0.426;Q2;68;34;79;1687;107;78;1.38;49.62;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2010-2021;Pharmaceutical Science (Q2)
362;4700152426;Current Pharmaceutical Analysis;journal;15734129;0.425;Q2;25;48;96;1591;141;95;1.47;33.15;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmaceutical Science (Q2); Biochemistry (Q3); Biophysics (Q3); Molecular Medicine (Q4)"
363;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.425;Q2;72;187;593;6935;870;588;1.63;37.09;United Kingdom;Western Europe;Taylor and Francis Ltd.;1961-1972, 1975-2021;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
364;27210;In Vivo;journal;17917549, 0258851X;0.419;Q3;64;152;445;5307;660;443;1.32;34.91;Greece;Western Europe;International Institute of Anticancer Research;1987-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
365;19700188326;American Journal of Drug Discovery and Development (discontinued);journal;2150427X, 21504296;0.415;Q3;12;16;18;670;58;18;3.22;41.88;United States;Northern America;Academic Journals Inc.;2011-2015;Drug Discovery (Q3)
366;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.413;Q3;46;92;233;3660;361;227;1.66;39.78;United Kingdom;Western Europe;Informa Healthcare;1991-2021;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
367;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0.412;Q3;42;23;83;1226;111;77;1.38;53.3;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q2); Cardiology and Cardiovascular Medicine (Q3); Hematology (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
368;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699, 09750983;0.409;Q1;48;121;427;3262;451;427;0.84;26.96;India;Asiatic Region;Scientific Publishers of India;1970, 1973-1978, 1981, 1989-1991, 1996-2018, 2020-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Organic Chemistry (Q3)"
369;16319;IEEE Transactions on Nanobioscience;journal;15361241, 15582639;0.408;Q2;65;49;112;1754;251;110;2.01;35.8;United States;Northern America;Institute of Electrical and Electronics Engineers Inc.;2002-2021;"Computer Science Applications (Q2); Electrical and Electronic Engineering (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3); Biomedical Engineering (Q3); Biotechnology (Q3); Nanoscience and Nanotechnology (Q3)"
370;19700201137;Journal of Advanced Pharmaceutical Technology and Research;journal;01105558, 09762094;0.405;Q2;38;43;86;1127;117;76;1.36;26.21;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2021;Pharmaceutical Science (Q2)
371;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.403;Q3;69;122;404;2728;501;378;1.13;22.36;Germany;Western Europe;Dustri-Verlag Dr. Karl Feistle;1994-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
372;4700152603;Medicinal Chemistry;journal;15734064, 18756638;0.402;Q3;46;139;199;4664;317;197;1.48;33.55;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;Drug Discovery (Q3)
373;21100218041;Anti-Infective Agents;journal;22113533, 22113525;0.399;Q3;24;27;43;1255;59;40;1.22;46.48;United Arab Emirates;Middle East;Bentham Science Publishers;2012-2021;"Infectious Diseases (Q3); Pharmacology (Q3)"
374;29947;Journal of Chemotherapy;journal;1120009X, 19739478;0.397;Q3;52;66;306;1796;354;257;0.96;27.21;United Kingdom;Western Europe;Maney Publishing;1989-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3)"
375;3500148011;Journal of Zhejiang University: Science B;journal;16731581;0.395;Q1;61;122;381;4116;568;378;1.45;33.74;China;Asiatic Region;Zhejiang University Press;2005-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Veterinary (miscellaneous) (Q2)"
376;5900153312;Recent Patents on Cardiovascular Drug Discovery;journal;15748901;0.394;Q3;28;27;81;2124;126;80;1.75;78.67;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006-2015;"Pharmacology (medical) (Q2); Cardiology and Cardiovascular Medicine (Q3); Drug Discovery (Q3)"
377;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.393;Q3;53;145;288;5493;424;287;1.46;37.88;United Kingdom;Western Europe;Informa Healthcare;1978-2021;"Medicine (miscellaneous) (Q2); Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3); Toxicology (Q3)"
378;19700175244;Current Radiopharmaceuticals;journal;18744710, 18744729;0.392;Q3;26;45;95;2173;99;86;1.23;48.29;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2009-2021;"Pharmacology (Q3); Radiology, Nuclear Medicine and Imaging (Q3)"
379;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.39;Q3;46;70;173;2484;233;173;1.47;35.49;United States;Northern America;Informa Healthcare;1977-2021;"Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
380;21100421502;International Journal of Biomedical Nanoscience and Nanotechnology;journal;17560802, 17560799;0.388;Q2;8;7;25;387;26;25;1.04;55.29;Switzerland;Western Europe;Inderscience Publishers;2011;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Biomedical Engineering (Q3)"
381;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.387;Q2;61;100;441;2476;529;440;0.86;24.76;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-2021;Pharmaceutical Science (Q2)
382;19700174891;Perspectives in Medicinal Chemistry;journal;11773910, 1177391X;0.382;Q2;16;0;8;0;13;8;0.6;0;New Zealand;Pacific Region;Libertas Academica Ltd.;2008-2011, 2014-2016;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
383;19700201609;Open Natural Products Journal;journal;18748481;0.379;Q3;3;3;3;41;3;3;1;13.67;Netherlands;Western Europe;;;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3)"
384;19700175086;Drug, Healthcare and Patient Safety;journal;11791365;0.375;Q3;25;17;51;826;64;49;1.22;48.59;New Zealand;Pacific Region;Dove Medical Press Limited;2009-2021;"Health Policy (Q2); Pharmacology (Q3)"
385;18384;Medicinal Chemistry Research;journal;10542523, 15548120;0.375;Q1;50;490;382;14263;578;381;1.42;29.11;United States;Northern America;Birkhauser Boston;1994, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Organic Chemistry (Q3)"
386;11200153563;Drug Metabolism Letters;journal;18740758, 18723128;0.374;Q2;28;29;112;1010;140;111;1.39;34.83;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2019, 2021;"Biochemistry (medical) (Q2); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Clinical Biochemistry (Q3)"
387;19400158813;HIV Therapy;journal;17584329, 17584310;0.371;Q3;12;0;108;0;70;79;0.77;0;United Kingdom;Western Europe;Future Medicine Ltd.;2009-2010;"Pharmacology (medical) (Q2); Dermatology (Q3); Drug Discovery (Q3); Infectious Diseases (Q3); Pharmacology (Q3); Virology (Q3)"
388;19700175060;International Journal of PharmTech Research (discontinued);journal;09744304;0.37;Q2;48;240;986;5254;1021;986;0.88;21.89;India;Asiatic Region;Sphinx Knowledge House;2009-2016;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
389;17700156434;Current Pharmacogenomics and Personalized Medicine;journal;18756913, 18756921;0.368;Q3;19;41;89;2194;140;72;1.24;53.51;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2008-2018, 2020;"Pharmacology (Q3); Genetics (Q4); Genetics (clinical) (Q4); Molecular Biology (Q4); Molecular Medicine (Q4)"
390;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.368;Q3;32;63;153;1624;198;150;1.31;25.78;United Kingdom;Western Europe;Informa Healthcare;1982-2000, 2005-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
391;10300153301;Expert Review of Clinical Pharmacology;journal;17512433, 17512441;0.365;Q1;46;79;195;4432;234;171;1.36;56.1;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
392;21717;Die Pharmazie;journal;00317144;0.364;Q2;66;180;504;4937;657;504;1.2;27.43;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-2021;Pharmaceutical Science (Q2)
393;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.364;Q2;66;78;161;2540;261;161;1.61;32.56;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1979-2021;"Chemistry (miscellaneous) (Q2); Pharmaceutical Science (Q2); Aging (Q3); Colloid and Surface Chemistry (Q3); Dermatology (Q3); Drug Discovery (Q3)"
394;17700155411;Research Journal of Environmental Toxicology (discontinued);journal;18193420;0.363;Q3;18;20;93;783;81;93;0.75;39.15;United States;Northern America;Academic Journals Inc.;2009-2016;"Health, Toxicology and Mutagenesis (Q3); Pollution (Q3); Toxicology (Q3)"
395;21192;Drug Development Research;journal;02724391, 10982299;0.358;Q3;62;61;192;2967;217;185;1.04;48.64;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;Drug Discovery (Q3)
396;19700200821;Therapeutic Delivery;journal;20415990, 20416008;0.357;Q2;52;130;213;8982;222;202;1.04;69.09;United Kingdom;Western Europe;Future Science;2010-2021;Pharmaceutical Science (Q2)
397;19700174931;Asian Journal of Pharmaceutics (discontinued);journal;1998409X, 09738398;0.352;Q1;23;39;145;1232;138;133;0.83;31.59;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2018, 2020-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
398;29634;Journal of Negative Results in BioMedicine;journal;14775751;0.352;Q1;23;16;38;476;43;37;1;29.75;United Kingdom;Western Europe;BioMed Central Ltd.;2002-2017;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q3)"
399;5400152628;Revista Brasileira de Farmacognosia;journal;0102695X, 1981528X;0.351;Q1;50;148;510;6155;497;498;0.91;41.59;Brazil;Latin America;Springer Nature Switzerland AG;2007-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
400;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.348;Q3;48;87;373;2089;305;371;0.74;24.01;United Kingdom;Western Europe;John Wiley and Sons Ltd;1976-2021;"Analytical Chemistry (Q3); Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Spectroscopy (Q3)"
401;59665;Chinese Journal of Natural Medicines;journal;16723651;0.346;Q3;40;90;213;2082;215;210;1.13;23.13;China;Asiatic Region;China Pharmaceutical University;2004-2021;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
402;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.34;Q2;45;172;333;4515;400;332;1.1;26.25;Poland;Eastern Europe;Polish Pharmaceutical Society;1951-1955, 1961-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
403;19700201521;Journal of Chemical and Pharmaceutical Research (discontinued);journal;09757384;0.34;Q2;39;528;634;11651;577;634;0.91;22.07;India;Asiatic Region;JOCPR;2004, 2011-2016;Pharmaceutical Science (Q2)
404;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.34;Q3;47;34;98;1624;136;98;1.2;47.76;United States;Northern America;Begell House Inc.;1984-1990, 1992-2021;"Health, Toxicology and Mutagenesis (Q3); Medicine (miscellaneous) (Q3); Pathology and Forensic Medicine (Q3); Toxicology (Q3)"
405;19700177128;Journal of Young Pharmacists (discontinued);journal;09751505, 09751483;0.34;Q1;30;48;139;1035;162;127;1.17;21.56;India;Asiatic Region;EManuscript Services;2010-2018, 2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
406;4500151530;Personalized Medicine;journal;17410541;0.339;Q3;33;100;240;2976;235;188;1.08;29.76;United Kingdom;Western Europe;Future Medicine Ltd.;2006-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
407;29845;IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer;book series;10171606;0.336;Q3;48;43;127;4408;132;119;1.04;102.51;France;Western Europe;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-2020;"Toxicology (Q3); Cancer Research (Q4)"
408;19900192174;International Journal of Applied Pharmaceutics;journal;09757058;0.333;Q2;20;7;14;130;15;14;1.07;18.57;India;Asiatic Region;International Journal of Applied Pharmaceutics;2011-2021;Pharmaceutical Science (Q2)
409;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.33;Q3;61;54;264;965;265;223;0.79;17.87;United Kingdom;Western Europe;FRAME;1982, 1985-1986, 1988-1989, 1994-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medical Laboratory Technology (Q2); Medicine (miscellaneous) (Q3); Toxicology (Q3)"
410;22357;IDrugs : the investigational drugs journal;journal;13697056, 20403410;0.33;Q3;35;0;335;0;295;335;1.11;0;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
411;19600156803;Journal of Medicinal Plant Research;journal;19960875;0.329;Q2;63;1;1494;29;1729;1488;1.03;29;Nigeria;Africa;Academic Journals;2009-2012;"Complementary and Alternative Medicine (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3); Plant Science (Q3)"
412;19700173005;Cancer Nanotechnology;journal;18686958, 18686966;0.328;Q2;29;7;20;280;23;19;1.15;40;United States;Northern America;Springer Science + Business Media;2010-2021;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Oncology (Q3); Physical and Theoretical Chemistry (Q3)"
413;130089;Toxin Reviews;journal;15569543, 15569551;0.328;Q3;46;7;56;531;71;54;1;75.86;United Kingdom;Western Europe;Informa Healthcare;1982-2021;Toxicology (Q3)
414;19700188399;Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.];journal;19349254, 19349262;0.326;Q3;28;16;62;503;40;49;0.62;31.44;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q3); Toxicology (Q3)"
415;19700177407;Interdisciplinary Toxicology;journal;13379569, 13376853;0.325;Q3;34;34;85;1261;135;80;1.51;37.09;Slovakia;Eastern Europe;Slovak Toxicology Society SETOX;2008-2020;"Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
416;130045;Journal of Applied Biomedicine;journal;12140287, 1214021X;0.324;Q2;33;17;72;757;109;71;1.27;44.53;Spain;Western Europe;Elsevier Espana;2005-2021;"Agricultural and Biological Sciences (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q3)"
417;3200147837;Journal of Exercise Science and Fitness;journal;1728869X;0.324;Q2;25;17;58;741;47;58;0.47;43.59;Singapore;Asiatic Region;Elsevier;2005-2021;"Pharmaceutical Science (Q2); Pharmacology (nursing) (Q2); Sports Science (Q3)"
418;130072;International Journal of Medicinal Mushrooms;journal;15219437;0.318;Q3;33;54;149;2199;149;148;0.9;40.72;United States;Northern America;Begell House Inc.;2005-2021;"Applied Microbiology and Biotechnology (Q3); Drug Discovery (Q3); Pharmacology (Q3)"
419;73430;Pharmaceutical Technology;journal;15432521;0.315;Q2;38;208;606;741;99;501;0.16;3.56;United States;Northern America;Advanstar Communications Inc.;1979-1985, 1987, 1996-2021;"Pharmaceutical Science (Q2); Biophysics (Q4)"
420;22456;International Journal of Pharmacy Practice;journal;09617671, 20427174;0.314;Q2;39;62;244;1664;178;221;0.63;26.84;United Kingdom;Western Europe;Oxford University Press;1991-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2); Health Policy (Q3); Medicine (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q3)"
421;21810;Farmacia;journal;00148237;0.311;Q2;27;95;264;1751;237;264;0.96;18.43;Romania;Eastern Europe;Romanian Society for Pharmaceutical Sciences;1945-1946, 1973-1987, 2003, 2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
422;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.311;Q2;51;223;543;5532;419;540;0.76;24.81;United States;Northern America;Taylor and Francis Ltd.;1996-2021;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Clinical Biochemistry (Q3)"
423;21264;Drugs in R and D;journal;11796901, 11745886;0.308;Q3;47;25;58;670;76;54;1.31;26.8;United Kingdom;Western Europe;Adis International Ltd;1999, 2002-2008, 2010-2021;Pharmacology (Q3)
424;19700201141;Journal of Ayurveda and Integrative Medicine;journal;09759476, 09762809;0.307;Q3;29;46;106;822;91;75;0.86;17.87;Netherlands;Western Europe;Wolters Kluwer Medknow Publications;2010-2021;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3)"
425;4700152608;African Journal of Traditional, Complementary and Alternative Medicines (discontinued);journal;25050044, 01896016;0.306;Q3;48;112;190;2476;257;190;1.07;22.11;Nigeria;Africa;African Ethnomedicines Network;2006-2017;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
426;20545;PDA Journal of Pharmaceutical Science and Technology;journal;19482124, 10797440;0.306;Q2;40;55;210;1203;163;187;0.66;21.87;United States;Northern America;Parenteral Drug Association Inc.;1994-2021;Pharmaceutical Science (Q2)
427;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.303;Q3;53;61;168;1206;145;142;0.62;19.77;India;Asiatic Region;Association of Physiologists and Pharmacologists of India;1959-2021;"Pharmacology (Q3); Physiology (medical) (Q3); Physiology (Q4)"
428;25144;Journal of Health Science;journal;13475207, 13449702;0.303;Q3;49;0;295;0;331;286;0.87;0;Japan;Asiatic Region;Pharmaceutical Society of Japan;1999-2011;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
429;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.302;Q4;37;71;164;2866;185;158;0.81;40.37;Croatia;Eastern Europe;Institute for Medical Research and Occupational Health;1953-2021;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q4)"
430;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0.301;Q3;34;19;58;653;38;54;0.55;34.37;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
431;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.301;Q3;62;195;401;3645;417;307;0.97;18.69;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-1980, 1982, 1984-1986, 1994-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
432;19200156909;Indian Journal of Pharmaceutical Education and Research;journal;00195464;0.3;Q2;22;58;166;1217;130;163;0.93;20.98;India;Asiatic Region;Association of Pharmaceutical Teachers of India;2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
433;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;0.3;Q2;48;144;222;4151;202;210;0.74;28.83;Iran;Middle East;Iranian Journal of Pharmaceutical Research;2002-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
434;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115, 20082231;0.299;Q3;47;100;162;3124;181;161;1.01;31.24;United Kingdom;Western Europe;BioMed Central Ltd.;2000-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
435;19700174933;Journal of Pharmaceutical Sciences and Research (discontinued);journal;09751459;0.295;Q2;30;83;300;1946;306;300;0.74;23.45;India;Asiatic Region;;2009-2018, 2020-2021;Pharmaceutical Science (Q2)
436;4700152769;Pharmacopeial Forum (discontinued);journal;03634655;0.294;Q3;19;11;66;62;44;47;0.26;5.64;United States;Northern America;United States Pharmacopeial Convention Inc.;1996-1998, 2000-2018;"Pharmacy (Q1); Drug Guides (Q3); Pharmacology (Q3)"
437;19700175119;Asian Journal of Pharmaceutical Sciences;journal;18180876, 2221285X;0.291;Q2;48;44;98;1704;73;98;0.57;38.73;China;Asiatic Region;Shenyang Pharmaceutical University;2009-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
438;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.29;Q2;57;51;140;1568;138;136;0.96;30.75;United States;Northern America;Informa Healthcare;2013-2021;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Biotechnology (Q3); Medicine (miscellaneous) (Q3)"
439;22205;Saudi Pharmaceutical Journal;journal;13190164;0.289;Q2;57;48;106;1453;138;104;1.59;30.27;Saudi Arabia;Middle East;King Saud University;1996-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
440;19383;Fluoride - Quarterly Reports;journal;22534083, 00154725;0.288;Q4;48;45;114;1115;129;106;1.01;24.78;New Zealand;Pacific Region;International Society for Fluoride Research;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q2); Dentistry (miscellaneous) (Q2); Chemistry (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q3); Biochemistry (Q4); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
441;19700174900;International Journal of Green Pharmacy (discontinued);journal;19984103, 09738258;0.288;Q2;26;59;185;1816;175;177;0.69;30.78;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2018, 2020-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
442;19700175778;International Journal of Research in Pharmaceutical Sciences (discontinued);journal;09757538;0.288;Q2;21;74;170;1557;140;170;0.82;21.04;India;Asiatic Region;"JK Welfare &amp; Pharmascope Foundation";2010-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
443;19500157062;Current Cardiovascular Risk Reports;journal;19329563, 19329520;0.285;Q3;30;75;203;4704;103;201;0.58;62.72;United States;Northern America;Current Medicine Group;2007-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
444;19927;Methods and Findings in Experimental and Clinical Pharmacology;journal;03790355;0.285;Q3;53;0;147;0;148;138;0.79;0;Spain;Western Europe;Prous Science;1979-2010;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
445;130038;Letters in Drug Design and Discovery;journal;15701808;0.284;Q2;35;129;345;3925;319;343;0.93;30.43;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Molecular Medicine (Q4)"
446;19700174889;Drug Target Insights;journal;11773928;0.283;Q2;13;4;3;209;3;3;0.5;52.25;Italy;Western Europe;AboutScience Srl;2008-2009, 2011-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Clinical Biochemistry (Q3); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
447;23489;Chemical Speciation and Bioavailability;journal;09542299;0.281;Q4;0;0;0;0;0;0;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1989-2018;"Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
448;19700174961;BioProcess International;trade journal;15426319;0.279;Q3;23;165;474;1428;275;454;0.57;8.65;United States;Northern America;PJB Publications Ltd.;2009-2017;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Drug Discovery (Q3)"
449;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.276;Q2;36;32;50;1549;58;47;0.94;48.41;Germany;Western Europe;Walter de Gruyter GmbH;2015-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
450;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.276;Q3;36;27;84;889;78;83;0.96;32.93;Germany;Western Europe;Walter de Gruyter GmbH;1985-1988, 1990-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Physiology (Q4)"
451;21496;Revista de Chimie (discontinued);journal;00347752;0.275;-;31;259;778;5214;424;776;0.58;20.13;Romania;Eastern Europe;Syscom 18 SRL;1973, 1996-2021;Chemistry (miscellaneous) (Q3)
452;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0.273;Q2;20;0;129;0;103;129;0.76;0;Turkey;Middle East;Istanbul Medipol University;2006-2011, 2016-2021;Pharmaceutical Science (Q2)
453;19700188319;International Journal of Pharmaceutical Sciences Review and Research (discontinued);journal;0976044X;0.273;Q2;33;302;674;7900;512;671;0.76;26.16;India;Asiatic Region;Global Research Online;2010-2016, 2020-2021;Pharmaceutical Science (Q2)
454;19200156945;Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas;journal;07177917;0.272;Q3;22;57;202;2061;133;181;0.66;36.16;Chile;Latin America;MS-Editions;2008-2021;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Pharmacology (Q3); Plant Science (Q3)"
455;19700175040;Open Vaccine Journal;journal;18750354;0.272;Q2;9;3;41;169;30;39;0.5;56.33;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2013;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Immunology (Q4)"
456;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.265;Q2;27;46;143;1427;116;124;0.97;31.02;France;Western Europe;Elsevier Masson s.r.l.;1945, 1947-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
457;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;21070180, 03787966;0.264;Q3;39;36;88;979;77;87;1.09;27.19;France;Western Europe;Springer Paris;1976-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
458;19700174904;Asian Journal of Pharmaceutical and Clinical Research (discontinued);journal;09742441, 24553891;0.26;Q2;41;400;353;9669;262;351;0.58;24.17;India;Asiatic Region;Asian Journal of Pharmaceutical and Clinical Research;2009-2018, 2020-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
459;19500157042;Currents in Pharmacy Teaching and Learning;journal;18771297;0.26;Q2;23;46;99;701;35;87;0.4;15.24;United States;Northern America;Elsevier Inc.;2009-2021;"Pharmacy (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
460;4000152107;Journal of Venomous Animals and Toxins Including Tropical Diseases;journal;16789199;0.257;Q4;32;67;209;1835;114;184;0.56;27.39;United Kingdom;Western Europe;Centro de Estudos de Venenos e Animais Peconhentos;2006-2021;"Animal Science and Zoology (Q3); Infectious Diseases (Q3); Parasitology (Q4); Toxicology (Q4)"
461;19900194914;Journal of Punjab Academy of Forensic Medicine and Toxicology;journal;0974083X, 09725687;0.256;Q4;7;29;28;357;6;25;0.21;12.31;India;Asiatic Region;Punjab Academy of Forensic Medicine and Toxicology;2011-2020;"Pathology and Forensic Medicine (Q3); Toxicology (Q4)"
462;18200156711;Bangladesh Journal of Pharmacology;journal;1991007X, 19910088;0.253;Q3;26;54;81;1383;106;81;0.78;25.61;Bangladesh;Asiatic Region;Bangladesh Pharmacological Society;2009-2021;Pharmacology (Q3)
463;19700201140;Systematic Reviews in Pharmacy (discontinued);journal;09758453, 09762779;0.253;Q2;28;7;42;428;51;41;1.21;61.14;India;Asiatic Region;EManuscript Technologies;2010-2021;Pharmaceutical Science (Q2)
464;21265;Drugs of the Future;journal;03778282;0.252;Q3;45;115;328;3879;192;327;0.47;33.73;Spain;Western Europe;Prous Science;1978-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
465;35190;Revista Espanola de Quimioterapia;journal;02143429;0.25;Q3;26;53;128;1431;100;106;0.79;27;Spain;Western Europe;Sociedad Espanola de Quiminoterapia;1989-2021;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3)"
466;22881;Yaoxue Xuebao;journal;05134870;0.25;Q2;34;266;751;6333;522;750;0.74;23.81;China;Asiatic Region;Chinese Pharmaceutical Association;1960, 1962-1966, 1979-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Molecular Medicine (Q4)"
467;19700171017;African Journal of Pharmacy and Pharmacology;journal;19960816;0.248;Q2;33;0;636;0;495;636;0.6;0;Nigeria;Africa;Academic Journals;2009-2011;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
468;21100209501;Statistics in Biopharmaceutical Research;journal;19466315;0.247;Q2;18;37;50;758;19;49;0.38;20.49;United Kingdom;Western Europe;Taylor and Francis Ltd.;2011-2021;"Pharmaceutical Science (Q2); Statistics and Probability (Q4)"
469;144879;Toxicology International;journal;09716580;0.247;Q4;28;55;75;1525;80;72;1.23;27.73;India;Asiatic Region;Society of Toxicology India;2005-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
470;145693;Canadian Pharmacists Journal;journal;17151635;0.244;Q3;24;107;305;872;59;145;0.22;8.15;Canada;Northern America;Canadian Pharmacists Association;2005-2021;"Pharmacy (Q2); Pharmaceutical Science (Q3)"
471;21100209502;Journal of Pharmacology and Pharmacotherapeutics;journal;0976500X, 09765018;0.244;Q3;37;100;108;1473;92;56;0.85;14.73;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
472;21100238633;BioImpacts;journal;22285652, 22285660;0.243;Q3;37;27;35;1203;21;32;0.6;44.56;Iran;Middle East;Tabriz University of Medical Sciences;2011-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3)"
473;19700175099;Topics in Medicinal Chemistry;book series;1862247X, 18622461;0.243;Q3;12;9;33;1105;13;25;0.26;122.78;Germany;Western Europe;Springer Verlag;2009-2012, 2014-2021;"Drug Discovery (Q3); Molecular Medicine (Q4)"
474;11900154394;Oriental Journal of Chemistry (discontinued);journal;0970020X, 22315039;0.241;Q3;27;262;746;6241;376;746;0.65;23.82;India;Asiatic Region;Bhopal, S.A. Iqbal;1989, 2008-2018, 2021;"Chemistry (miscellaneous) (Q3); Drug Discovery (Q3); Biochemistry (Q4); Environmental Chemistry (Q4)"
475;18800156730;Biomolecules and Therapeutics;journal;19769148, 20054483;0.239;Q3;44;80;192;3528;146;192;0.83;44.1;South Korea;Asiatic Region;Korean Society of Applied Pharmacology;2008-2021;"Drug Discovery (Q3); Pharmacology (Q3); Biochemistry (Q4); Molecular Medicine (Q4)"
476;5400152620;American Journal of Pharmacology and Toxicology (discontinued);journal;15574970, 15574962;0.238;Q2;21;20;66;606;55;66;0.49;30.3;United States;Northern America;Science Publications;2007-2016;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
477;37697;Autonomic and Autacoid Pharmacology;journal;14748673, 14748665;0.238;Q3;21;7;49;265;34;49;0.31;37.86;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2002-2017;Pharmacology (Q3)
478;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X, 1414431X;0.236;Q2;91;184;525;6235;760;519;1.35;33.89;Brazil;Latin America;Associacao Brasileira de Divulgacao Cientifica;1973-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Biochemistry (Q4); Biophysics (Q4); Cell Biology (Q4); Immunology (Q4); Neuroscience (miscellaneous) (Q4); Physiology (Q4)"
479;4600151506;Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry;journal;18715222;0.235;Q3;14;34;78;2748;37;70;0.39;80.82;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2018;"Endocrinology, Diabetes and Metabolism (Q3); Pharmacology (Q3); Immunology and Allergy (Q4)"
480;19700175006;Thai Journal of Pharmaceutical Sciences;journal;01254685, 19054637;0.234;Q3;12;74;43;875;44;43;0.94;11.82;Thailand;Asiatic Region;Thai Journal of Pharmaceutical Sciences;2009-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
481;11100153314;Frontiers in Medicinal Chemistry;book series;18755763, 15742042;0.231;Q3;7;0;44;0;16;42;0;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006, 2009-2010;"Drug Discovery (Q3); Molecular Medicine (Q4); Organic Chemistry (Q4)"
482;4700152701;Pharmacy Practice;journal;1885642X, 18863655;0.231;Q3;28;33;108;944;70;106;0.67;28.61;Spain;Western Europe;Centro de Investigaciones y Publicaciones Farmaceuticas;2006-2021;"Pharmacy (Q2); Pharmaceutical Science (Q3)"
483;21758;Prescrire International;journal;11677422;0.231;Q3;13;196;613;1239;122;559;0.2;6.32;France;Western Europe;Association Mieux Prescrire;1996-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
484;16698;Revista Brasileira de Plantas Medicinais;journal;1983084X, 15160572;0.23;Q3;29;103;212;3071;100;210;0.34;29.82;Brazil;Latin America;Instituto de Biociencias;1999-2016;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
485;17700156705;Modern Trends in Pharmacopsychiatry;journal;16622685, 16624505;0.229;Q3;0;0;0;0;0;0;0;0;Switzerland;Western Europe;S. Karger AG;2009-2010, 2013, 2015, 2017;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Psychiatry and Mental Health (Q3)"
486;144963;Drug Discovery Today: Disease Models;journal;17406757;0.228;Q3;28;33;65;1830;44;56;0.67;55.45;United Kingdom;Western Europe;Elsevier Ltd.;2004-2020;"Drug Discovery (Q3); Molecular Medicine (Q4)"
487;19700180522;Molecular and Cellular Toxicology;journal;20928467, 1738642X;0.228;Q2;23;50;100;1604;80;100;0.8;32.08;Germany;Western Europe;Springer Verlag;2010-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pathology and Forensic Medicine (Q3); Public Health, Environmental and Occupational Health (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
488;19600157763;Research in Pharmaceutical Sciences;journal;17355362, 17359414;0.227;Q2;33;33;38;930;43;38;1.08;28.18;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
489;19700175120;Journal of Pharmaceutical Research and Health Care;journal;09753648;0.225;Q2;9;0;57;0;39;52;0.68;0;India;Asiatic Region;;2010-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
490;19446;American Pharmaceutical Review;journal;10998012;0.224;Q3;24;82;252;1300;104;247;0.39;15.85;United States;Northern America;Russell Publishing LLC;2002-2020;Pharmaceutical Science (Q3)
491;15600154705;EnvironmentAsia;journal;19061714;0.224;Q4;19;23;96;588;60;96;0.59;25.57;Thailand;Asiatic Region;Thai Society of Higher Eduation Institutes on Environment;2009-2021;"Environmental Science (miscellaneous) (Q3); Toxicology (Q4)"
492;19700201144;Journal of Pharmacy and Bioallied Sciences;journal;09764879, 09757406;0.224;Q2;42;136;89;2699;72;67;0.81;19.85;India;Asiatic Region;Wolters Kluwer Medknow Publications;2011-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Bioengineering (Q4)"
493;20578;Journal of Food and Drug Analysis;journal;10219498;0.223;Q3;63;148;176;3998;103;176;0.43;27.01;Taiwan;Asiatic Region;National Laboratories of Foods and Drugs;1994-2021;"Food Science (Q3); Pharmacology (Q3)"
494;19700175858;Journal of Pharmacognosy and Phytotherapy (discontinued);journal;21412502;0.223;Q3;22;15;36;352;43;36;1.19;23.47;United States;Northern America;Academic Journals Inc.;2010-2017;Drug Discovery (Q3)
495;4700152607;Current Enzyme Inhibition;journal;15734080;0.221;Q3;18;12;68;1077;49;65;0.65;89.75;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Drug Discovery (Q3); Biochemistry (Q4); Molecular Medicine (Q4)"
496;19700188318;International Journal of Advances in Pharmaceutical Sciences (discontinued);journal;09761055;0.219;Q3;11;0;57;0;48;57;0.84;0;United States;Northern America;Advanced Research Journals;2010-2011;"Pharmaceutical Science (Q3); Physical and Theoretical Chemistry (Q4)"
497;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.219;Q2;19;32;122;800;39;107;0.36;25;United States;Northern America;SAGE Publications Inc.;2000-2015, 2017-2018;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Marketing (Q3); Medicine (miscellaneous) (Q3); Strategy and Management (Q3)"
498;19700175121;Azerbaijan Pharmaceutical and Pharmacotherapy Journal;journal;19941951;0.218;Q2;3;17;73;257;9;73;0.19;15.12;Azerbaijan;Eastern Europe;Azerbaijan Medical University;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
499;21100236605;Journal of Applied Pharmaceutical Science;journal;22313354;0.217;Q2;41;407;326;11175;235;325;0.72;27.46;India;Asiatic Region;MediPoeia;2011-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
500;19700175096;Pharmacognosy Journal;journal;09753575;0.217;Q3;25;89;316;2138;150;314;0.47;24.02;India;Asiatic Region;EManuscript Technologies;2009-2021;"Drug Discovery (Q3); Pharmacology (Q3)"
501;19400157518;Rasayan Journal of Chemistry;journal;09760083, 09741496;0.216;Q2;24;74;442;1380;188;442;0.36;18.65;India;Asiatic Region;Rasayan Journal;2008-2021;"Energy (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Chemical Engineering (miscellaneous) (Q3); Chemistry (miscellaneous) (Q3); Biochemistry (Q4)"
502;19700200880;Botulinum Journal;journal;17547326, 17547318;0.215;Q2;6;10;23;188;15;20;0.73;18.8;Switzerland;Western Europe;Inderscience Publishers;2009-2013, 2016;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry (Q4); Cellular and Molecular Neuroscience (Q4)"
503;19700174811;European Journal of Parenteral and Pharmaceutical Sciences;journal;17406277, 09644679;0.215;Q3;6;25;34;349;11;27;0.32;13.96;United Kingdom;Western Europe;Pharmaceutical and Healthcare Sciences Society;2010-2016, 2018-2021;"Pharmacy (Q2); Pharmaceutical Science (Q3)"
504;22854;Yakugaku Zasshi;journal;13475231, 00316903;0.215;Q3;43;57;662;947;337;603;0.49;16.61;Japan;Asiatic Region;Pharmaceutical Society of Japan;1961-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
505;19700201333;International Journal of Drug Delivery (discontinued);journal;09750215;0.213;Q3;15;20;63;553;42;63;0.67;27.65;United States;Northern America;Advanced Research Journals;2011-2015;Pharmaceutical Science (Q3)
506;79053;Natural Product Sciences;journal;12263907;0.213;Q3;28;47;160;1176;65;160;0.35;25.02;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1997-2021;"Drug Discovery (Q3); Organic Chemistry (Q4)"
507;19700188309;Journal of Bioanalysis and Biomedicine (discontinued);journal;1948593X;0.211;Q3;11;25;40;822;36;40;0.9;32.88;United States;Northern America;OMICS Publishing Group;2010-2014;Pharmaceutical Science (Q3)
508;19900192116;Journal of Pharmaceutical Analysis;journal;20951779;0.211;Q3;38;76;40;1508;27;40;0.68;19.84;China;Asiatic Region;Xi'an Jiaotong University;2011-2021;"Pharmacy (Q2); Drug Discovery (Q3); Pharmaceutical Science (Q3); Analytical Chemistry (Q4); Electrochemistry (Q4); Spectroscopy (Q4)"
509;19700174658;Regulatory Rapporteur;trade journal;17428955;0.211;Q2;6;77;135;410;16;101;0.12;5.32;United Kingdom;Western Europe;TOPRA;2010-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacy (Q2)"
510;15500154707;International Journal of Biological Chemistry (discontinued);journal;21522561, 1819155X;0.21;Q3;16;16;63;473;78;61;1.27;29.56;Pakistan;Asiatic Region;Asian Network for Scientific Information;2009-2016;"Pharmacology (Q3); Biochemistry (Q4)"
511;13718;Pharmaceutical Engineering;journal;02738139;0.21;Q3;16;58;152;365;26;134;0.12;6.29;United States;Northern America;Int. Society for Pharmaceutical Engineering, Inc.;1996-2018;Pharmaceutical Science (Q3)
512;19700200724;Der Pharmacia Lettre (discontinued);journal;09755071;0.209;Q3;28;247;280;5080;128;280;0.46;20.57;India;Asiatic Region;Scholars Research Library;2011-2016;Pharmaceutical Science (Q3)
513;21100470510;Drug Research;journal;21949379, 21949387;0.208;Q3;65;131;365;3007;223;358;0.62;22.95;Germany;Western Europe;Thieme;1972, 2013-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
514;19700201201;EPMA Journal;journal;18785077, 18785085;0.208;Q3;39;13;107;879;77;96;0.72;67.62;United Kingdom;Western Europe;BioMed Central Ltd.;2010-2021;"Biochemistry (medical) (Q3); Drug Discovery (Q3); Health Policy (Q3)"
515;19700181240;Global Journal of Pharmacology (discontinued);journal;19920075;0.208;Q2;18;28;47;899;38;47;0.81;32.11;Pakistan;Asiatic Region;International Digital Organization for Scientific Information;2010-2014;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
516;144613;Journal of Generic Medicines (discontinued);journal;17411343;0.208;Q3;15;29;111;224;33;97;0.25;7.72;United Kingdom;Western Europe;SAGE Publications Inc.;2003-2015, 2017, 2021;Pharmaceutical Science (Q3)
517;21100242405;Marmara Pharmaceutical Journal;journal;13090801;0.207;Q2;0;0;0;0;0;0;0;0;Turkey;Middle East;Marmara University;2010-2019;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
518;19700188355;International Journal of Phytomedicine (discontinued);journal;09750185;0.206;Q4;20;63;127;1739;85;127;0.67;27.6;United States;Northern America;Advanced Research Journals;2010-2016;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q4)"
519;19700189100;Pharmaceutical Medicine;journal;11782595, 11791993;0.206;Q3;19;26;93;724;44;58;0.58;27.85;United Kingdom;Western Europe;Adis International Ltd;2000-2001, 2008-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
520;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.204;Q2;43;86;285;2692;162;278;0.51;31.3;Brazil;Latin America;Faculdade de Ciencias Farmaceuticas (Biblioteca-;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
521;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;journal;18715125;0.202;Q3;21;13;26;845;8;0;0.33;65;United States;Northern America;Academic Press Inc.;2001-2003, 2005, 2007-2021;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
522;21811;Farmacia Hospitalaria;journal;21718695, 11306343;0.201;Q3;24;115;237;2207;105;114;0.37;19.19;Spain;Western Europe;Grupo Aula Medica S.A.;1990-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
523;19700175758;International Journal of Drug Development and Research (discontinued);journal;09759344;0.201;Q2;24;181;284;4692;157;283;0.55;25.92;India;Asiatic Region;International Journal of Drug Development and Research;2010-2015;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
524;19700175061;Open Pharmacology Journal;journal;18741436;0.201;Q3;6;5;10;400;11;10;1.8;80;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2013;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
525;25253;Blutalkohol (discontinued);journal;00065250;0.2;Q4;13;25;118;330;9;110;0.04;13.2;Germany;Western Europe;Steintor-Verlag GmbH;1974-2017, 2020-2021;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
526;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X, 15232859;0.199;Q3;20;139;381;531;107;334;0.32;3.82;United States;Northern America;Medical Letter Inc.;1965-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
527;21100205919;Open Drug Discovery Journal;journal;18773818;0.199;Q4;9;0;26;0;16;23;0.62;0;United Arab Emirates;Middle East;Bentham open;2010, 2014;Drug Discovery (Q4)
528;19700174978;American Journal of Pharmacy Benefits;journal;21642494, 19454481;0.198;Q2;15;56;110;1220;32;91;0.29;21.79;United States;Northern America;Managed Care and Healthcare Communications;2010-2018;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Business and International Management (Q3); Decision Sciences (miscellaneous) (Q3)"
529;21100431352;Proceedings of ISMA 2010 - International Conference on Noise and Vibration Engineering, including USD 2010;conference and proceedings;-;0.196;-;13;0;387;0;188;386;0.49;0;Belgium;Western Europe;;;"Health, Toxicology and Mutagenesis; Toxicology"
530;21100301409;Issues in Toxicology;book series;17577179, 17577187;0.195;Q3;16;72;68;6768;52;64;0.72;94;United Kingdom;Western Europe;Royal Society of Chemistry;2007-2021;"Pharmacology (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
531;12328;Current Therapeutic Research;journal;0011393X, 18790313;0.194;Q3;42;18;100;510;61;96;0.58;28.33;United States;Northern America;Elsevier Inc.;1959-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
532;58808;Pharmaceutical Care and Research;journal;16712838;0.193;Q3;8;151;484;1301;42;479;0.09;8.62;China;Asiatic Region;Publishing House of Pharmaceutical Care and Research;2004-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
533;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.193;Q3;19;215;641;1830;59;627;0.1;8.51;Germany;Western Europe;Editio Cantor Verlag GmbH;1960-1961, 1973-2019;Pharmaceutical Science (Q3)
534;19700174893;Dhaka University Journal of Pharmaceutical Sciences (discontinued);journal;18161839, 18161820;0.192;Q3;13;28;73;520;28;73;0.3;18.57;Bangladesh;Asiatic Region;University of Dhaka;2007-2018, 2020;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
535;11100153311;Iranian Journal of Pharmacology and Therapeutics;journal;17352657;0.19;Q3;21;9;45;255;33;45;0.63;28.33;Iran;Middle East;Academy of Medical Sciences of I.R. Iran;2006-2015;Pharmacology (Q3)
536;19700200861;International Journal of Pharmaceutical Sciences;journal;09754725;0.189;Q3;11;61;79;1828;42;79;0.53;29.97;India;Asiatic Region;R R College of Pharmacy;2010, 2012-2013;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
537;21100199816;Jundishapur Journal of Natural Pharmaceutical Products;journal;22287876, 17357780;0.189;Q3;24;34;7;656;2;7;0.29;19.29;Netherlands;Western Europe;Kowsar Publishing Company;2011-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
538;21083;Pharmaceutical Care Espana (discontinued);journal;11396202;0.189;Q3;9;33;77;457;11;57;0.08;13.85;Spain;Western Europe;Fundacion Pharamaceutical Care Espana;2001-2017;"Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3)"
539;20065;BioPharm International;trade journal;1542166X, 19391862;0.188;Q3;29;143;317;583;86;286;0.26;4.08;United States;Northern America;Advanstar Communications Inc.;2002-2020;"Biotechnology (Q3); Pharmaceutical Science (Q3)"
540;5800173394;Current Drug Therapy;journal;15748855;0.187;Q3;17;36;97;2407;47;91;0.36;66.86;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2021;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
541;19700188422;Research Journal of Pharmaceutical, Biological and Chemical Sciences (discontinued);journal;09758585;0.187;Q3;31;552;767;11627;305;767;0.4;21.06;India;Asiatic Region;RJPBCS;2010-2017, 2020-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
542;19700174971;Indian Journal of Forensic Medicine and Toxicology (discontinued);journal;09739122, 09739130;0.186;Q4;12;120;184;1664;12;183;0.05;13.87;India;Asiatic Region;Institute of Medico-legal Publications;2008-2021;"Law (Q3); Health, Toxicology and Mutagenesis (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
543;80593;Journal of Medicinal Plants;journal;16840240;0.186;Q3;23;84;256;2762;105;256;0.31;32.88;Iran;Middle East;;2004-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
544;19200156925;Cancer Therapy;journal;15439143, 15439135;0.184;Q3;8;2;68;74;32;68;0.1;37;United States;Northern America;Gene Therapy Press;2009-2014;"Oncology (Q3); Pharmacology (Q3); Cancer Research (Q4)"
545;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;0.183;Q3;24;35;109;2441;65;98;0.47;69.74;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Immunology (Q4); Immunology and Allergy (Q4)"
546;19700175124;Open Neuropsychopharmacology Journal;journal;18765238;0.183;Q3;5;3;20;238;11;19;0.38;79.33;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2012;"Pharmacology (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3)"
547;22908;Chinese Pharmacological Bulletin;journal;10011978;0.18;Q3;17;417;1304;6771;518;1304;0.44;16.24;China;Asiatic Region;Institute of Clinical Pharmacology;1993-2020;Pharmacology (Q3)
548;17300154738;Current Trends in Biotechnology and Pharmacy;journal;22307303, 09738916;0.18;Q3;14;49;151;1809;71;151;0.29;36.92;India;Asiatic Region;Association of Biotechnology and Pharmacy;2009-2021;"Biotechnology (Q3); Pharmaceutical Science (Q3); Drug Discovery (Q4)"
549;11400153330;Recent Patents on Endocrine, Metabolic and Immune Drug Discovery;journal;18722148, 22123334;0.179;Q4;25;25;75;2498;55;74;0.94;99.92;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2008-2017;"Biochemistry (medical) (Q3); Endocrinology, Diabetes and Metabolism (Q3); Medicine (miscellaneous) (Q3); Drug Discovery (Q4); Immunology and Allergy (Q4)"
550;6400153143;Turkish Journal of Pharmaceutical Sciences;journal;1304530X;0.179;Q3;16;33;74;999;32;74;0.37;30.27;Turkey;Middle East;Turkish Pharmacists  Association;2006-2021;"Pharmaceutical Science (Q3); Molecular Medicine (Q4)"
551;19700201423;Journal of Pharmaceutical Health Services Research;journal;17598885, 17598893;0.178;Q3;16;36;64;918;29;56;0.45;25.5;United Kingdom;Western Europe;Oxford University Press;2010-2021;"Economics, Econometrics and Finance (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
552;19381;Acta Farmaceutica Bonaerense;journal;03262383;0.177;Q3;0;0;0;0;0;0;0;0;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
553;19700200708;Journal of Global Pharma Technology (discontinued);journal;09758542;0.177;Q3;17;34;185;744;86;178;0.46;21.88;India;Asiatic Region;Journal of Global Pharma Technology;2010-2020;Pharmaceutical Science (Q3)
554;21100241608;Journal of Nanomedicine and Nanotechnology (discontinued);journal;21577439;0.177;Q3;24;48;29;1654;21;26;0.72;34.46;United States;Northern America;OMICS Publishing Group;2010-2014;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Bioengineering (Q4); Biomedical Engineering (Q4)"
555;17700156303;Neuromethods;book series;19406045, 08932336;0.177;Q3;21;117;440;7471;117;408;0.25;63.85;United States;Northern America;Humana Press;2009-2022;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Psychiatry and Mental Health (Q3); Neuroscience (miscellaneous) (Q4)"
556;19700175125;Internet Journal of Pharmacology;journal;15312976;0.176;Q3;8;0;71;0;40;71;0.47;0;United States;Northern America;Internet Scientific Publications, LLC;2009-2011;Pharmacology (Q3)
557;17600155051;Drug Development and Delivery;trade journal;1944818X, 15372898;0.174;Q3;11;83;266;441;54;209;0.18;5.31;United States;Northern America;Drug Delivery Technology;2009-2021;Pharmaceutical Science (Q3)
558;24097;Journal of the Indian Chemical Society;journal;00194522;0.174;Q4;33;232;687;6768;220;679;0.31;29.17;India;Asiatic Region;Elsevier BV;1973-1985, 1987-1991, 1996-2021;"Drug Discovery (Q4); Electrochemistry (Q4); Inorganic Chemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
559;22934;Chinese Pharmaceutical Journal;journal;10012494;0.173;Q3;21;498;1470;7099;307;1469;0.2;14.26;China;Asiatic Region;Chinese Pharmaceutical Association;1993-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
560;110097;Food and Drug Law Journal;journal;1064590X;0.173;Q4;22;23;92;4024;38;91;0.28;174.96;United States;Northern America;Food and Drug Law Institute;1992-2018, 2021;"Law (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q4); Public Health, Environmental and Occupational Health (Q4)"
561;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185, 22312730;0.173;Q3;35;172;528;2438;146;355;0.34;14.17;India;Asiatic Region;Wolters Kluwer Medknow Publications;1996-1999, 2002-2021;"Anesthesiology and Pain Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
562;19900191846;PharmacoEconomics - German Research Articles;journal;1868677X, 16123727;0.173;Q3;3;8;13;336;9;12;0.69;42;New Zealand;Pacific Region;Adis Press;2010-2012;"Economics, Econometrics and Finance (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
563;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.172;Q3;9;47;173;931;21;162;0.1;19.81;Cuba;Latin America;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-2021;"Pharmaceutical Science (Q3); Pharmacy (Q3); Pharmacology (Q4)"
564;21100212330;Drug Discoveries and Therapeutics;journal;1881784X, 18817831;0.171;Q3;27;13;101;24;37;101;0.37;1.85;Japan;Asiatic Region;"International Advancement Center for Medicine &amp; Health Research Co., Ltd. (IACMHR Co., Ltd.)";1997, 2010-2018, 2020;"Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
565;21100376682;Toxicologie Analytique et Clinique;journal;23520078;0.171;Q4;9;23;31;585;7;26;0.23;25.43;France;Western Europe;Elsevier Masson s.r.l.;2014-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
566;19700175071;Open Bioactive Compounds Journal;journal;18748473;0.17;Q3;6;0;6;0;9;6;0.33;0;Netherlands;Western Europe;;;"Pharmaceutical Science (Q3); Biochemistry (Q4); Drug Discovery (Q4); Molecular Biology (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
567;5800179590;Pharmacologyonline (discontinued);journal;18278620;0.17;Q4;27;76;1086;2419;258;1084;0.23;31.83;Italy;Western Europe;SILAE - Societa Italo-Latinoamericana di Etnomedicina;2007-2021;"Drug Discovery (Q4); Pharmacology (Q4)"
568;19978;Ars Pharmaceutica (discontinued);journal;00042927;0.168;Q3;20;25;235;477;56;233;0.08;19.08;Spain;Western Europe;Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017, 2021;"History and Philosophy of Science (Q3); Pharmaceutical Science (Q3)"
569;21100226424;Toxicology and Environmental Health Sciences;journal;20059752, 22337784;0.168;Q4;17;36;105;1292;44;105;0.47;35.89;South Korea;Asiatic Region;Korean Society of Environmental Risk Assessment and Health Science;2009-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
570;19700175149;African Journal Biomedical Research;journal;11195096;0.167;Q3;17;33;72;743;28;71;0.39;22.52;Nigeria;Africa;Ibadan Biomedical Communications Group;2008, 2010-2021;"Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
571;19700182039;International Journal of Green Nanotechnology: Biomedicine;journal;1943085X, 19430906;0.166;Q3;15;63;46;1891;29;45;0.31;30.02;United States;Northern America;Taylor and Francis Ltd.;2009-2012;"Pharmaceutical Science (Q3); Biomedical Engineering (Q4); Nanoscience and Nanotechnology (Q4)"
572;19700174628;Iranian Journal of Basic Medical Sciences;journal;20083874, 20083866;0.166;Q4;44;84;119;2736;66;119;0.52;32.57;Iran;Middle East;Mashhad University of Medical Sciences;2007-2021;"Biochemistry (Q4); Biophysics (Q4); Clinical Biochemistry (Q4); Drug Discovery (Q4); Immunology and Microbiology (miscellaneous)  (Q4)"
573;130031;Journal of Toxicologic Pathology;journal;09149198;0.166;Q4;30;34;102;932;48;102;0.41;27.41;Japan;Asiatic Region;Japanese Society of Toxicologic Pathology;1988-1990, 1992-2021;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
574;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.166;Q3;10;35;81;195;6;80;0.06;5.57;France;Western Europe;Editions de Sante;1991-2014, 2017-2018;Pharmaceutical Science (Q3)
575;21412;Zeitschrift fur Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.166;Q4;13;52;197;621;25;138;0.15;11.94;Germany;Western Europe;Hippokrates Verlag GmbH;1982, 1985-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
576;19700175056;Jordan Journal of Pharmaceutical Sciences;journal;19957157;0.164;Q3;10;22;59;610;23;59;0.35;27.73;Jordan;Middle East;The University of Jordan;2009-2021;Pharmaceutical Science (Q3)
577;21100325142;Journal of Pharmaceutical Policy and Practice;journal;20523211;0.164;Q3;21;16;33;449;9;24;0.27;28.06;United Kingdom;Western Europe;BioMed Central Ltd.;2013-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health Policy (Q4)"
578;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.164;Q3;18;72;132;2475;47;131;0.33;34.38;Brazil;Latin America;Universidade Estadual Paulista - UNESP;2005-2021;Pharmaceutical Science (Q3)
579;19500156813;Procedia in Vaccinology;journal;1877282X;0.163;Q3;15;21;110;409;36;108;0.31;19.48;Netherlands;Western Europe;Elsevier;2009-2012;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Immunology (Q4); Infectious Diseases (Q4)"
580;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.161;Q4;29;31;90;998;33;90;0.3;32.19;United States;Northern America;Taylor and Francis Ltd.;1992-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
581;19700171709;Arhiv za Farmaciju;journal;00041963;0.16;Q3;4;41;101;1113;7;101;0.03;27.15;Serbia;Eastern Europe;Farmaceutsko Drustvo Srbije;1954-1955, 2009-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
582;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.16;Q3;32;787;2152;8107;682;2151;0.28;10.3;China;Asiatic Region;Zhongguo Zhongyi Yanjiuyuan;1989-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
583;19900192173;International Journal of Pharmaceutical and Clinical Research (discontinued);journal;09751556;0.159;Q3;13;17;18;264;4;18;0.22;15.53;Australia;Pacific Region;International Journal of Pharmaceutical and Clinical Research;2011-2016;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Drug Discovery (Q4)"
584;19900192163;Results in Pharma Sciences;journal;22112863;0.158;Q3;16;13;11;397;7;11;0.64;30.54;Netherlands;Western Europe;Elsevier BV;2011-2016;Pharmaceutical Science (Q3)
585;19600161802;International Journal of Computational Biology and Drug Design;journal;17560764, 17560756;0.157;Q4;14;23;77;585;31;72;0.4;25.43;United Kingdom;Western Europe;Inderscience Enterprises Ltd;2008-2021;"Computer Science Applications (Q4); Drug Discovery (Q4)"
586;19700175785;Open Access Journal of Clinical Trials;journal;11791519;0.157;Q3;12;16;34;685;27;32;0.9;42.81;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
587;19700170837;Vitae;journal;21452660, 01214004;0.157;Q3;15;25;103;944;36;96;0.25;37.76;Colombia;Latin America;Universidad de Antioquia;2009-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Applied Microbiology and Biotechnology (Q4); Bioengineering (Q4); Biotechnology (Q4); Food Science (Q4)"
588;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0.156;Q3;17;11;45;155;11;41;0.18;14.09;United States;Northern America;Informa Healthcare;1983-1990, 1992-2016;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
589;19700174645;International Journal of Pharmaceutical Research (discontinued);journal;09752366;0.156;Q3;24;103;111;2258;52;107;0.47;21.92;India;Asiatic Region;Advanced Scientific Research;2010-2021;"Pharmaceutical Science (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
590;20564;Ceska a Slovenska Farmacie;journal;12107816;0.155;Q3;17;42;114;1197;27;110;0.27;28.5;Czech Republic;Eastern Europe;Czech Medical Association J.E. Purkyne;1994-2021;Pharmaceutical Science (Q3)
591;19700181241;Physiology and Pharmacology;journal;17350581;0.155;Q4;12;55;146;1907;37;146;0.23;34.67;Iran;Middle East;Neuroscience Research Center;2009-2021;"Pharmacology (Q4); Physiology (Q4)"
592;15842;Journal of Applied Research;journal;1537064X;0.153;Q4;22;13;48;366;23;45;0.48;28.15;United States;Northern America;The Journal of Applied Research;2001-2014;"Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
593;19700174997;ONdrugDelivery;trade journal;2049145X, 20491468;0.152;Q3;6;46;86;120;13;75;0.15;2.61;United Kingdom;Western Europe;Frederick Furness Publishing;2009-2020;Pharmaceutical Science (Q3)
594;21100196907;Open Toxinology Journal;journal;18754147;0.152;Q4;2;0;1;0;1;1;1;0;Netherlands;Western Europe;;;"Pharmacology (medical) (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
595;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X;0.15;Q4;10;171;315;3194;41;315;0.12;18.68;Poland;Eastern Europe;Uniwersytet Medyczny w Lublinie;2012-2021;"Medicine (miscellaneous) (Q3); Biochemistry (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
596;19700175029;Pharmacogenomics and Personalized Medicine;journal;11787066;0.15;Q4;31;11;31;914;13;31;0.55;83.09;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Molecular Medicine (Q4); Pharmacology (Q4)"
597;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074, 09728066;0.149;Q4;11;6;27;61;4;20;0.12;10.17;India;Asiatic Region;Anil Aggrawal;2000-2020;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
598;21932;Hindustan Antibiotics Bulletin;journal;00181935;0.149;Q4;9;0;7;0;5;7;0;0;India;Asiatic Region;Hindustan Antibiotics Ltd.;1960-1961, 1965-2000, 2002-2003, 2005, 2007, 2009;Pharmacology (Q4)
599;70864;Anales de la Real Academia Nacional de Farmacia (discontinued);journal;1697428X, 16974271;0.148;Q3;10;29;81;808;22;71;0.21;27.86;Spain;Western Europe;Real Academia Nacional de Farmacia;1988-2018;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Cell Biology (Q4); Molecular Biology (Q4)"
600;22375;Indian Drugs;journal;0019462X;0.148;Q3;31;84;380;1882;65;380;0.16;22.4;India;Asiatic Region;Indian Drug Manufacturers' Association;1989-2021;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
601;21100791826;Journal of Traditional Medicines;journal;18813747, 18801447;0.148;Q4;12;15;68;297;19;68;0.21;19.8;Japan;Asiatic Region;Medical and Pharmaceutical Society for WAKAN-YAKU;2004-2013;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4)"
602;145096;Neuropsychopharmacologia Hungarica;journal;14198711;0.148;Q3;17;30;80;1429;33;67;0.4;47.63;Hungary;Eastern Europe;Hungarian Association of Psychopharmacology;2004-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4)"
603;50105;Japanese Journal of Neuropsychopharmacology;journal;03887588, 13434144;0.147;Q4;11;50;103;1021;30;94;0.3;20.42;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1982-1997, 2002-2017;"Pharmacology (medical) (Q3); Clinical Psychology (Q4); Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
604;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0.147;Q4;22;23;84;502;24;84;0.24;21.83;India;Asiatic Region;Informatics Publishing Limited;2002-2021;Pharmacology (Q4)
605;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.147;Q4;34;162;452;2606;102;406;0.21;16.09;United States;Northern America;Springer New York;1967-2021;"Drug Discovery (Q4); Pharmacology (Q4)"
606;19700188484;Journal of Bioequivalence and Bioavailability (discontinued);journal;09750851;0.146;Q3;12;35;58;660;21;54;0.36;18.86;United States;Northern America;OMICS Publishing Group;2011-2014;Pharmaceutical Science (Q3)
607;19408;Actualites Pharmaceutiques;journal;05153700;0.145;Q4;5;243;490;757;15;445;0.03;3.12;Netherlands;Western Europe;Elsevier;1961, 1963, 1996-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
608;15340;Developments in Biologicals;journal;14246074, 16622960;0.144;Q4;38;20;1;0;1;1;1;0;Switzerland;Western Europe;S. Karger AG;2000-2008, 2010, 2012-2013;"Biomaterials (Q4); Immunology (Q4); Pharmacology (Q4)"
609;19700170617;EXCLI Journal;journal;16112156;0.144;Q4;43;81;92;3106;176;81;2.27;38.35;Germany;Western Europe;Leibniz Research Centre for Working Environment and Human Factors;2009-2021;"Animal Science and Zoology (Q4); Drug Discovery (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
610;22514;Japanese Journal of Chemotherapy;journal;13407007;0.144;Q4;12;23;123;457;12;123;0.12;19.87;Japan;Asiatic Region;Japan Society of Chemotherapy;1995-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
611;19700174970;Hacettepe University Journal of the Faculty of Pharmacy;journal;13000608;0.143;Q3;7;12;36;655;9;36;0.22;54.58;Turkey;Middle East;Hacettepe University, Faculty of Pharmacy;2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
612;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.143;Q4;14;46;109;1022;26;103;0.19;22.22;Cuba;Latin America;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-2020;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
613;19500157008;Fooyin Journal of Health Sciences;journal;18778607, 18778615;0.142;Q4;6;0;35;0;16;33;0.52;0;Netherlands;Western Europe;Elsevier BV;2009-2010;"Medicine (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Drug Discovery (Q4)"
614;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.142;Q4;14;20;52;6;9;52;0.19;0.3;Japan;Asiatic Region;Nihon Sangyo Eisei Gakkai;1995-2021;"Medicine (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
615;22338;Hospital Pharmacy;journal;19451253, 00185787;0.141;Q4;24;132;465;1684;61;387;0.1;12.76;United States;Northern America;Thomas Land Publishers Inc.;1973-2021;"Pharmacology (medical) (Q3); Pharmacy (Q3); Pharmacology (Q4)"
616;94365;Journal of Phytomedicine and Therapeutics;journal;11181028;0.14;Q4;6;0;11;0;4;11;0;0;Nigeria;Africa;National Institute for Pharmaceutical Research and Development;2000-2003, 2007, 2009, 2015-2016;Pharmacology (Q4)
617;21100304895;Archives of Clinical Infectious Diseases;journal;23452641;0.139;Q4;17;27;143;463;38;126;0.19;17.15;Iran;Middle East;Shahid Beheshti University of Medical Sciences;2012-2021;"Cardiology and Cardiovascular Medicine (Q3); Critical Care and Intensive Care Medicine (Q3); Infectious Diseases (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
618;21100804474;European Pharmaceutical Journal;journal;24536725;0.139;Q3;8;27;43;459;3;41;0.14;17;Germany;Western Europe;de Gruyter;2016-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
619;15240;Iranian Journal of Medical Sciences;journal;17353688, 02530716;0.139;-;31;48;170;1151;45;153;0.22;23.98;Iran;Middle East;Shiraz University of Medical Sciences;1979-1981, 1989-2021;Medicine (miscellaneous) (Q3)
620;23171;Korean Journal of Pharmacognosy;journal;02533073;0.139;Q3;17;0;166;0;37;166;0.18;0;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1990-2011, 2013-2021;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
621;22825;Proceedings of the Western Pharmacology Society;journal;00838969;0.139;Q4;24;0;72;0;22;72;0.11;0;United States;Northern America;Western Pharmacology Society;1960-1969, 1973-2011;Pharmacology (Q4)
622;19400157142;Chiang Mai University Journal of Natural Sciences;journal;16851994;0.138;-;12;79;89;1536;27;88;0.12;19.44;Thailand;Asiatic Region;Chiang Mai University;2003, 2006, 2009-2021;Multidisciplinary (Q3)
623;22979;Journal of Applied Therapeutic Research;journal;10292659;0.138;Q4;8;5;30;206;8;30;0.25;41.2;United Kingdom;Western Europe;Euromed Communications;1998-2000, 2003-2012;Pharmacology (Q4)
624;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.138;Q4;10;0;45;0;14;42;0.23;0;Netherlands;Western Europe;Brill Academic Publishers;1995, 1997, 2001, 2004-2006, 2008-2011, 2013-2021;"Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Virology (Q4)"
625;19700201471;International Journal of Pharmacy and Technology (discontinued);journal;0975766X;0.137;Q3;23;149;240;3316;51;239;0.21;22.26;India;Asiatic Region;International Journal of Pharmacy and Technology(IJPT);2011-2016;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biomedical Engineering (Q4)"
626;22906;Journal of China Pharmaceutical University;journal;10005048;0.137;Q3;14;107;334;1706;57;333;0.2;15.94;China;Asiatic Region;China Pharmaceutical University;1989-1991, 2002-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
627;19700175137;Trends in Medical Research (discontinued);journal;18193587, 21516065;0.137;Q3;10;6;28;350;16;28;0.42;58.33;United States;Northern America;Academic Journals Inc.;2008-2016, 2020-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Medicine (miscellaneous) (Q4)"
628;19900193266;International Journal of Ayurveda Research;journal;0974925X, 09747788;0.136;Q3;7;0;19;0;9;10;0.47;0;India;Asiatic Region;Wolters Kluwer Medknow Publications;2011;Pharmaceutical Science (Q3)
629;19700183012;Iranian Journal of Pharmaceutical Sciences;journal;17352444;0.136;Q3;13;24;66;560;17;66;0.26;23.33;Iran;Middle East;Iranian Association of Pharmaceutical Scientists;2010-2014, 2016-2021;"Pharmaceutical Science (Q3); Bioengineering (Q4)"
630;20400195018;International Journal of Pharmacognosy and Phytochemical Research (discontinued);journal;09754873;0.135;Q4;19;36;23;640;6;23;0.26;17.78;India;Asiatic Region;International Journal of Pharmacognosy and Phytochemical Research;2011-2016, 2020;Drug Discovery (Q4)
631;21100199811;Stamford Journal of Pharmaceutical Sciences;journal;19997108;0.135;Q3;9;0;26;0;6;26;0.23;0;Bangladesh;Asiatic Region;Department of Pharmacy, Stamford University Bangladesh;2011;Pharmaceutical Science (Q3)
632;21100201958;Journal of Chinese Pharmaceutical Sciences;journal;10031057;0.134;Q3;13;75;81;2167;21;81;0.26;28.89;China;Asiatic Region;Editorial Office of Journal of Chinese Pharmaceutical Sciences;2011-2021;Pharmaceutical Science (Q3)
633;19399;Acta Pharmaceutica Hungarica (discontinued);journal;00016659;0.133;Q4;14;16;54;478;14;53;0.32;29.88;Hungary;Eastern Europe;Magyar Gyogyszereszeti Tarsasag;1965-2018;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4)"
634;73076;Drug Discovery World;journal;14694344;0.133;Q4;13;42;147;503;34;132;0.22;11.98;United Kingdom;Western Europe;RJ Communications and Media Ltd.;2004-2018;Drug Discovery (Q4)
635;21795;Farmaceuticky Obzor (discontinued);journal;00148172;0.133;Q4;7;34;97;333;5;93;0.05;9.79;Slovakia;Eastern Europe;Postgraduate Medical and Pharmaceutical School;1961-1963, 1974, 1976-2016;Pharmaceutical Science (Q4)
636;19700189400;Pharmaceutical Sciences;journal;23832886, 1735403X;0.133;Q3;19;30;94;997;13;94;0.1;33.23;Iran;Middle East;Tabriz University of Medical Sciences;2009-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
637;21211;Pharmacy Education;journal;14772701, 15602214;0.133;Q4;18;9;69;196;9;69;0.15;21.78;Netherlands;Western Europe;;1973-1978, 2002-2021;"Pharmacy (Q3); Education (Q4); Pharmaceutical Science (Q4)"
638;5200152604;Pharma Times;journal;00316849;0.133;Q3;12;85;241;441;33;189;0.12;5.19;India;Asiatic Region;Indian Pharmaceutical Association;2006-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
639;21100201517;RSC Drug Discovery Series;book series;20413203, 20413211;0.133;Q4;10;0;28;0;2;11;0.07;0;United Kingdom;Western Europe;Royal Society of Chemistry;2010, 2014-2021;Drug Discovery (Q4)
640;19700200860;International Journal of Current Pharmaceutical Review and Research (discontinued);journal;0976822X;0.132;Q4;14;16;32;273;12;32;0.38;17.06;India;Asiatic Region;Publishers, In-IJCPR;2010-2017;Pharmaceutical Science (Q4)
641;19700175002;Pharmaceutical Reviews;journal;19185561;0.132;Q4;5;0;57;0;22;57;0.28;0;Canada;Northern America;;2009-2011;"Analytical Chemistry (Q4); Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
642;20572;PZ Prisma;journal;09455566;0.132;Q4;5;32;102;663;5;91;0.04;20.72;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1994-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
643;19700188437;Open Access Journal of Medicinal and Aromatic Plants;journal;09747877;0.131;Q4;7;1;13;13;5;12;0.38;13;India;Asiatic Region;Medicinal and Aromatic Plants Association of India;2010-2019;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4)"
644;21102;Pharmaceutical Journal;journal;00316873;0.131;Q4;28;795;2548;360;41;833;0.01;0.45;United Kingdom;Western Europe;Pharmaceutical Press;1945-1949, 1994-2012, 2014-2017;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
645;21100197929;Toxicological Research;journal;19768257, 22342753;0.131;Q4;35;40;85;973;11;85;0.12;24.33;South Korea;Asiatic Region;Koreal Association of Medical Journal Editors;2008-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
646;19800188037;2010 IEEE International Conference on Nano/Molecular Medicine and Engineering, IEEE NANOMED 2010;conference and proceedings;-;0.13;-;5;0;53;0;15;50;0.28;0;United States;Northern America;;;"Molecular Medicine; Pharmacology"
647;4000148308;Chinese Traditional and Herbal Drugs;journal;02532670;0.13;Q4;17;520;1189;7980;179;1189;0.14;15.35;China;Asiatic Region;Editorial Office of Chinese Traditional and Herbal Drugs;2006-2021;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
648;9100153105;Current Topics in Pharmacology;journal;09724559;0.13;Q4;6;11;39;637;8;39;0.21;57.91;India;Asiatic Region;Research Trends;2006-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
649;21798;Farmaceutski Glasnik;journal;00148202;0.129;Q4;6;69;219;655;6;179;0.02;9.49;Croatia;Eastern Europe;Hrvatsko Farmaceutsko Drustvo;1950-1951, 1962, 1990-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
650;21100244805;Journal of Vaccines and Vaccination (discontinued);journal;21577560;0.129;Q4;12;54;24;1716;10;23;0.42;31.78;United States;Northern America;OMICS Publishing Group;2010-2014;"Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Virology (Q4)"
651;130170;Phytotherapie;journal;17652847, 16248597;0.129;Q4;18;66;193;1462;23;159;0.13;22.15;France;Western Europe;Springer Paris;2005-2020;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
652;19700174926;International Journal of Health Research;journal;15969819, 15969886;0.128;Q4;9;5;83;110;25;81;0.04;22;Nigeria;Africa;Poracom Academic Publishers;2009-2012;"Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
653;9800153137;Trastornos Adictivos;journal;15750973;0.128;Q4;9;19;85;561;10;61;0.12;29.53;Spain;Western Europe;Ediciones Doyma, S.L.;2007-2012;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
654;5900153315;Pharmacoeconomics - Spanish Research Articles;journal;1695405X;0.127;Q3;6;15;43;463;10;36;0.26;30.87;Switzerland;Western Europe;Springer Science + Business Media;2007-2018;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health Policy (Q4)"
655;10900153328;Frontiers in Drug Design and Discovery;book series;15740889, 22121064;0.125;Q4;9;0;18;0;3;17;0;0;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2007, 2009, 2016-2018;"Drug Discovery (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4)"
656;23107;Journal of Pharmacy Technology;journal;15494810, 87551225;0.125;Q4;13;35;100;844;15;97;0.09;24.11;United States;Northern America;SAGE Publications Inc.;1989-2021;Pharmaceutical Science (Q4)
657;19700174925;European Pharmaceutical Review;trade journal;13608606;0.124;Q3;8;49;102;968;20;94;0.22;19.76;United Kingdom;Western Europe;Russell Publishing LLC;2009-2019;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Biophysics (Q4); Biotechnology (Q4); Molecular Medicine (Q4)"
658;5200152843;Farmaceutico Hospitales;journal;02144697;0.124;Q4;3;10;39;135;2;25;0.08;13.5;Spain;Western Europe;Ediciones Mayo S.A.;2006-2012;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
659;6800153106;International Journal of Essential Oil Therapeutics;journal;19614209;0.123;Q4;13;0;45;0;15;44;0.21;0;France;Western Europe;Essential Oil Resource Consultants;2007-2010;"Complementary and Alternative Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
660;19700172219;ISB 2010 Proceedings - International Symposium on Biocomputing;conference and proceedings;-;0.123;-;5;0;50;0;11;48;0.22;0;United States;Northern America;;;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Computational Theory and Mathematics; Pharmaceutical Science; Software"
661;25197;Revista de Toxicologia (discontinued);journal;02127113;0.123;Q4;11;23;38;734;7;38;0.07;31.91;Spain;Western Europe;Asociacion Espanola de Toxicologia;1989-2017, 2020;Toxicology (Q4)
662;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;0.122;Q4;14;66;149;1280;18;149;0.13;19.39;United Kingdom;Western Europe;Taylor and Francis Ltd.;1992, 2004-2013, 2015-2019;"Demography (Q4); Environmental Science (miscellaneous) (Q4); Toxicology (Q4)"
663;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.122;Q4;18;23;72;764;14;72;0.02;33.22;Turkey;Middle East;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-2021;Pharmaceutical Science (Q4)
664;22977;Journal de Pharmacie de Belgique;journal;00472166;0.122;Q4;12;30;86;389;10;83;0.15;12.97;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1946-2015;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
665;19700177006;Psychopharm Review;trade journal;19369255;0.122;Q4;4;12;36;420;11;36;0.33;35;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2009-2014;"Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
666;21100469670;Antibiotics;journal;20796382;0.121;Q3;47;5;1;133;0;1;0;26.6;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2010, 2012-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Infectious Diseases (Q4); Microbiology (Q4); Microbiology (medical) (Q4); Pharmacology (medical) (Q4)"
667;21100788810;Chemotherapy Research and Practice;journal;20902107;0.121;Q3;5;0;1;0;0;1;0;0;United States;Northern America;;;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Oncology (Q4); Pharmacology (medical) (Q4)"
668;21100785531;International Journal of Medicinal and Aromatic Plants;journal;22494340;0.121;Q4;3;1;1;163;0;1;0;163;India;Asiatic Region;;;"Drug Discovery (Q4); Plant Science (Q4)"
669;21100781436;Journal of Experimental Pharmacology;journal;11791454;0.121;Q4;15;2;1;192;0;1;0;96;New Zealand;Pacific Region;Dove Medical Press Ltd.;2010, 2012-2021;"Molecular Medicine (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
670;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0.121;Q4;9;29;91;1205;14;71;0.14;41.55;Mexico;Latin America;Asociacion Farmaceutica Mexicana A.C.;1997-2015;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
671;5100152606;Biosciences Biotechnology Research Asia (discontinued);journal;09731245;0.12;Q4;18;126;446;3033;25;446;0.06;24.07;India;Asiatic Region;Oriental Scientific Publishing Company;2005-2016;"Agronomy and Crop Science (Q4); Biotechnology (Q4); Drug Discovery (Q4)"
672;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.12;Q4;12;144;274;3259;38;274;0.11;22.63;China;Asiatic Region;Chinese Journal of Pharmacology and Toxicology;1986-2020;"Pharmacology (Q4); Toxicology (Q4)"
673;21100237602;Journal of Pharmacy and Nutrition Sciences (discontinued);journal;19275951, 22233806;0.12;Q3;12;24;27;780;8;27;0.3;32.5;Canada;Northern America;;2011-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health (social science) (Q4); Medicine (miscellaneous) (Q4); Nutrition and Dietetics (Q4)"
674;19800188074;Medicinal Plants - International Journal of Phytomedicines and Related Industries;journal;09754261, 09756892;0.12;Q4;10;46;82;1083;17;82;0.21;23.54;Netherlands;Western Europe;IOS Press BV;2010-2021;"Drug Discovery (Q4); Organic Chemistry (Q4); Plant Science (Q4)"
675;21127;Pharmaceutical Technology Europe;journal;01646826;0.12;Q4;18;56;373;185;29;295;0.06;3.3;United States;Northern America;Advanstar Communications Inc.;1998-2020;Pharmaceutical Science (Q4)
676;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.119;Q4;15;122;338;2095;52;335;0.11;17.17;Russian Federation;Eastern Europe;Izdatelstvo Meditsina;1992-2021;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4)"
677;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.119;Q4;10;19;126;573;19;117;0.01;30.16;Netherlands;Western Europe;IOS Press BV;1999, 2001-2002, 2005, 2007-2018;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
678;21800;Farmacevtski Vestnik (discontinued);journal;00148229;0.118;Q4;4;53;158;1515;9;142;0.06;28.58;Slovenia;Eastern Europe;Slovenian Pharmaceutical Society;1961, 1989-2016;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
679;19700175098;Klinicka Farmakologie a Farmacie;journal;12127973, 18035353;0.118;Q4;5;39;125;1025;16;109;0.15;26.28;Czech Republic;Eastern Europe;SOLEN S.R.O.;2009-2021;"Pharmacy (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4)"
680;19700175602;Next Generation Pharmaceutical;trade journal;-;0.118;Q4;1;0;221;0;1;132;0;0;United Kingdom;Western Europe;GDS International;2009-2011;"Drug Discovery (Q4); Marketing (Q4); Organizational Behavior and Human Resource Management (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Strategy and Management (Q4)"
681;19700175039;Open Toxicology Journal;journal;18743404;0.118;Q4;8;2;15;132;7;15;0.38;66;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2010, 2012-2013;Toxicology (Q4)
682;19700182785;Ethiopian Pharmaceutical Journal;journal;10295933;0.117;Q4;5;0;15;0;2;15;0;0;Ethiopia;Africa;Ethiopian Pharmaceutical Journal;2009;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
683;21100265336;International Arabic Journal of Antimicrobial Agents (discontinued);journal;21749094;0.117;Q4;8;18;6;563;1;5;0.17;31.28;Spain;Western Europe;Internet Medical Publishing;2011-2015;"Microbiology (medical) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
684;22887;Chinese Journal of Antibiotics;journal;10018689;0.116;Q4;11;179;526;3213;44;523;0.08;17.95;China;Asiatic Region;Editorial Office of Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
685;13000154717;Current Topics in Toxicology;journal;09728228;0.116;Q4;7;8;18;758;2;18;0.15;94.75;India;Asiatic Region;Research Trends;2007-2009, 2011-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
686;19200156912;EJHP Practice;trade journal;20303769, 17819989;0.116;Q4;6;0;288;0;37;218;0.13;0;Belgium;Western Europe;Pharma Publishing and Media Europe;2008-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
687;19700201404;Open Drug Safety Journal;journal;18768180;0.116;Q4;3;0;10;0;2;10;0.2;0;Netherlands;Western Europe;;;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
688;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0.116;Q4;6;35;123;210;13;111;0.12;6;United States;Northern America;Russell Publishing LLC;2010-2018, 2021;"Health Policy (Q4); Pharmaceutical Science (Q4)"
689;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.115;Q4;16;83;254;1207;24;254;0.12;14.54;Japan;Asiatic Region;Life Science Publishing Co. Ltd;1981-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
690;19700175034;Pharmaceutical Processing;trade journal;10499156;0.113;Q4;3;116;152;194;5;101;0.03;1.67;United States;Northern America;Advantage Business Media;2009-2018;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
691;21823;Pharmacia;journal;04280296;0.113;Q4;16;13;38;387;4;38;0.07;29.77;Bulgaria;Eastern Europe;Pensoft Publishers;1945, 1954-1955, 1987-1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
692;22358;U.S. Pharmacist;trade journal;01484818;0.113;Q4;9;158;435;2469;32;381;0.08;15.63;United States;Northern America;Jobson Publishing Corporation;1979, 1990-1996, 2007-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
693;21238;Drug Topics;journal;19378157, 00126616;0.112;Q4;8;230;645;274;8;158;0.01;1.19;United States;Northern America;Advanstar Communications Inc.;1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
694;21797;Farmaceutisch Tijdschrift voor Belgie;journal;07712367;0.112;Q4;3;25;57;376;5;54;0.11;15.04;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1978-2013;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
695;20500195212;International Journal of Drug Delivery Technology;journal;09754415;0.112;Q4;10;37;17;942;1;17;0.06;25.46;India;Asiatic Region;Dr. Yashwant Research Labs Pvt. Ltd.;2011-2012, 2014-2021;Pharmaceutical Science (Q4)
696;19700175031;Research Journal of Pharmacology (discontinued);journal;19936019, 18159362;0.112;Q4;9;12;50;429;14;50;0.24;35.75;Pakistan;Asiatic Region;Medwell Publishing;2008-2014, 2016;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
697;19700175108;Drug Delivery System;journal;18812732, 09135006;0.111;Q4;8;25;88;766;3;88;0.02;30.64;Japan;Asiatic Region;Japan Society of Drug Delivery System;1986, 1988-2021;Pharmaceutical Science (Q4)
698;21100199794;Industrial Pharmacy;trade journal;17414911;0.111;Q4;4;21;19;156;2;19;0.11;7.43;United Kingdom;Western Europe;Euromed Communications;2011-2016;Pharmaceutical Science (Q4)
699;21100204506;International Journal of Pharmaceutical Quality Assurance;journal;09759506;0.111;Q4;7;0;2;0;0;2;0;0;India;Asiatic Region;Dr. Yashwant Research Labs Pvt. Ltd.;2011, 2013-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
700;23009;Journal of Clinical Research;journal;13695207;0.111;Q4;11;0;2;0;0;2;0;0;United Kingdom;Western Europe;PJB Publications Ltd.;1998-2009;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
701;19900193894;Open Pharmacoeconomics and Health Economics Journal;journal;18768245;0.111;Q4;3;4;2;152;1;2;0.5;38;Netherlands;Western Europe;;;"Economics, Econometrics and Finance (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
702;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.111;Q4;5;12;35;164;2;35;0.09;13.67;Japan;Asiatic Region;Japanese Society of Oral Therapeutics and Pharmacology;1982-2021;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
703;21142;Pharmaceutisch Weekblad;journal;00316911;0.111;Q4;9;417;1249;687;16;955;0.01;1.65;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);1948-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
704;21243;Pharmacy Times;trade journal;00030627;0.111;Q4;8;320;596;1222;14;485;0.03;3.82;United States;Northern America;Intellisphere LLC;1977-1987, 2007-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
705;21716;Pharmazeutische Zeitung;journal;00317136;0.111;Q4;7;576;1536;560;9;898;0.01;0.97;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
706;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.11;Q4;19;109;289;1525;20;277;0.08;13.99;Japan;Asiatic Region;Japanese Pharmacological Society;1944, 1947-1948, 1951-1956, 1958-2021;Pharmacology (Q4)
707;19700201410;Milestones in Drug Therapy;book series;22966056;0.11;Q4;5;49;59;4127;7;58;0.12;84.22;United States;Northern America;Springer Science + Business Media;2010-2017;"Drug Discovery (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
708;19700174609;Clinical Medicine Insights: Therapeutics;journal;1179559X;0.109;Q4;10;22;83;1600;13;83;0.16;72.73;New Zealand;Pacific Region;Libertas Academica Ltd.;2010-2018;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
709;21718;Pharmazie in Unserer Zeit;journal;00483664, 16151003;0.109;Q4;13;74;243;1128;31;221;0.11;15.24;Germany;Western Europe;Wiley-VCH Verlag;1972-2012;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
710;21100232413;Advanced Pharmaceutical Bulletin;journal;22517308, 22285881;0.108;Q4;42;40;14;1073;3;14;0.21;26.83;Iran;Middle East;Tabriz University of Medical Sciences, Faculty of Pharmacy;2011-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
711;19700174922;Chinese Journal of New Drugs;journal;10033734;0.108;Q4;12;628;1242;9893;74;1242;0.06;15.75;China;Asiatic Region;Chinese Journal of New Drugs Co. Ltd.;2008-2021;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
712;20543;Pharmacometrics;journal;03008533;0.108;Q4;6;14;55;221;4;55;0.05;15.79;Japan;Asiatic Region;Japanese Society of Pharmacometrics;1973-2004, 2009-2012;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
713;17716;Quality Assurance Journal;journal;10991786, 10878378;0.108;Q4;9;0;45;0;9;40;0.08;0;United Kingdom;Western Europe;John Wiley and Sons Ltd;1998, 2000-2007, 2009-2011;"Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
714;21100197160;Research Journal of Pharmacy and Technology;journal;09743618, 0974360X;0.108;Q4;47;292;399;6778;22;399;0.06;23.21;India;Asiatic Region;A and V Publication;1997, 2005, 2011-2021;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
715;19700174940;SA Pharmaceutical Journal;journal;10151362;0.108;Q4;7;130;474;899;18;293;0.04;6.92;South Africa;Africa;Medpharm Publications;2009-2021;Pharmaceutical Science (Q4)
716;21100229846;2010 International Symposium on Waterborne Pathogens;conference and proceedings;-;0.107;-;1;0;33;0;1;32;0.03;0;United States;Northern America;;;"Health, Toxicology and Mutagenesis; Toxicology"
717;19700174924;Biomedical and Pharmacology Journal;journal;09746242;0.107;Q4;22;63;227;1217;16;227;0.06;19.32;India;Asiatic Region;Oriental Scientific Publishing Company;2009-2021;Pharmacology (Q4)
718;17783;Research Communications in Molecular Pathology and Pharmacology;journal;10780297;0.107;Q4;39;0;6;0;1;6;0;0;United States;Northern America;PJD Publications Ltd;1994-2007, 2009;"Medicine (miscellaneous) (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
719;20628;Circular Farmaceutica;journal;00097314;0.106;Q4;3;30;98;389;1;84;0.02;12.97;Spain;Western Europe;Col-legi de Farmaceutics de la Provincia de Barcelona;1961, 1973-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
720;21100216519;Journal of Pharmaceutical Negative Results;journal;09769234, 22297723;0.106;Q4;6;0;41;0;5;34;0.12;0;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2011, 2013-2021;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
721;21100201952;Arsenic in Geosphere and Human Diseases, As 2010 - 3rd International Congress: Arsenic in the Environment;conference and proceedings;-;0.105;-;5;0;221;0;16;216;0.07;0;United States;Northern America;;;"Health, Toxicology and Mutagenesis; Toxicology"
722;19900194805;Genomic Medicine, Biomarkers, and Health Sciences;journal;22114254, 22114262;0.105;Q4;7;34;19;430;2;18;0.11;12.65;Taiwan;Asiatic Region;Elsevier Taiwan LLC;2011-2012;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Drug Discovery (Q4); Medicine (miscellaneous) (Q4)"
723;10600153336;Innovations in Pharmaceutical Technology;trade journal;14717204;0.105;Q4;9;17;151;79;14;144;0.05;4.65;United Kingdom;Western Europe;Samedan Ltd;2007-2010, 2012-2019;Pharmaceutical Science (Q4)
724;19700181314;2009 IEEE 3rd International Conference on Nano/Molecular Medicine and Engineering, NANOMED 2009;conference and proceedings;-;0.104;-;5;0;71;0;8;70;0;0;United States;Northern America;;;"Molecular Medicine; Pharmacology"
725;19700174923;Farmaceutyczny Przeglad Naukowy;journal;14255073;0.104;Q4;3;0;99;0;12;98;0.12;0;Poland;Eastern Europe;Grupa Dr. A. R. Kwiecinskiego;2010-2011;Pharmaceutical Science (Q4)
726;19700201516;Journal of Chemical and Pharmaceutical Sciences (discontinued);journal;09742115;0.104;Q4;25;29;110;461;4;110;0.04;15.9;India;Asiatic Region;SPB Pharma Society;2010-2016;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
727;10300153375;Taiwan Pharmaceutical Journal;journal;10161015;0.104;Q4;5;0;5;0;0;5;0;0;Taiwan;Asiatic Region;Pharmaceutical Society of Republic of China;2007, 2009;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
728;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0.103;Q4;6;36;106;0;1;106;0;0;Spain;Western Europe;Real Academia de Farmacia;1949-2012, 2014;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
729;21000195625;Asian Journal of Pharmaceutical Research and Health Care (discontinued);journal;22501444, 22501460;0.103;Q4;6;16;10;311;1;7;0.1;19.44;India;Asiatic Region;;2011-2016;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
730;19700174992;European Journal of Oncology Pharmacy;journal;17833914;0.103;Q4;4;37;85;316;5;68;0.05;8.54;Belgium;Western Europe;Pharma Publishing and Media Europe;2008-2015, 2017-2019;"Oncology (Q4); Pharmacology (Q4)"
731;21100205709;International Journal of Toxicological and Pharmacological Research (discontinued);journal;09755160;0.103;Q4;10;17;6;617;0;6;0;36.29;India;Asiatic Region;Dr. Yashwant Research Labs Pvt. Ltd.;2011-2016;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
732;19700175049;Internet Journal of Toxicology;journal;15593916;0.103;Q4;7;0;41;0;5;41;0.04;0;United States;Northern America;Internet Scientific Publications, LLC;2009-2011, 2013, 2015;Toxicology (Q4)
733;19700201509;Pharma Research (discontinued);journal;09758216;0.103;Q4;5;25;46;730;2;45;0.04;29.2;India;Asiatic Region;Sudarshan Publications;2011-2016;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
734;19900195040;Therapeutics, Pharmacology and Clinical Toxicology;journal;20660170, 15830012;0.103;Q4;3;40;62;760;6;60;0.1;19;Romania;Eastern Europe;Rp Publishing House;2011-2012, 2014-2016;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
735;88685;Annual Report of Shionogi Research Laboratory;journal;05598680;0.102;Q4;2;0;11;0;0;9;0;0;Japan;Asiatic Region;Shionogi Co. Ltd;1972-1974, 1987-2009, 2015;Pharmacology (Q4)
736;9800153152;Archivos Venezolanos de Farmacologia y Terapeutica;journal;07980264;0.102;Q4;8;19;57;350;3;47;0.03;18.42;Venezuela;Latin America;Sociedad Latinoamericana de Hipertension;2007-2013, 2015-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
737;19700174886;Arzneimitteltherapie;journal;07236913;0.102;Q4;6;160;417;870;11;206;0.04;5.44;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;2008-2021;"Pharmacology (nursing) (Q3); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
738;21100204921;Bulletin of Pharmaceutical Sciences;journal;11100052;0.102;Q4;8;13;59;408;3;59;0.06;31.38;Egypt;Africa/Middle East;Faculty of Pharmacy, Assiut University;2008-2014, 2018-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
739;19700174892;Chinese Journal of Cancer Biotherapy;journal;1007385X;0.102;Q4;5;0;374;0;7;370;0.01;0;China;Asiatic Region;Editorial office of Chinese Journal of Cancer Biotherapy;2008-2011, 2013-2016, 2018-2022;"Cancer Research (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
740;21100829255;Chinese Journal of Pharmaceutical Biotechnology;journal;10058915;0.102;Q4;5;131;336;2095;14;336;0.02;15.99;China;Asiatic Region;China Pharmaceutical University;2007-2021;"Applied Microbiology and Biotechnology (Q4); Pharmaceutical Science (Q4)"
741;50087;EBR - European Biopharmaceutical Review;journal;13690663;0.102;Q4;5;61;178;401;6;177;0.03;6.57;United Kingdom;Western Europe;Samedan Ltd;2004-2019;Pharmaceutical Science (Q4)
742;21867;Geneesmiddelenbulletin;journal;03044629;0.102;Q4;7;65;173;687;3;72;0.03;10.57;Netherlands;Western Europe;Stichting Geneesmiddelenbulletin;1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
743;19900192735;International Drug Discovery;journal;21504806, 21504792;0.102;Q4;4;4;28;136;2;28;0.07;34;United States;Northern America;Russell Publishing LLC;2011-2012;Drug Discovery (Q4)
744;4000148821;International Journal of Pharmaceutical Compounding;journal;10924221;0.102;Q4;11;75;434;0;13;401;0.03;0;United States;Northern America;International Journal of Pharmaceutical Compounding;2006-2021;"Pharmacology (nursing) (Q3); Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
745;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;18828272, 03881601;0.102;Q4;7;95;332;770;3;322;0.02;8.11;Japan;Asiatic Region;Japanese Society of Clinical Pharmacology and Therapeutics;1970-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
746;18098;Japanese Journal of Psychopharmacology;journal;13402544;0.102;Q4;0;0;0;0;0;0;0;0;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1981-2016;"Clinical Psychology (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
747;4700151603;Journal of Pharmacy of Istanbul University;journal;03677524;0.102;Q4;9;10;11;306;0;11;0;30.6;Turkey;Middle East;University of Istanbul;2005, 2007-2008, 2010, 2012, 2015-2016;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
748;13637;Manufacturing Chemist;trade journal;02624230;0.102;Q4;6;135;295;306;6;268;0.02;2.27;United Kingdom;Western Europe;Wilmington Publishing;1981-1984, 1986, 1989, 1996-2001, 2006-2021;Pharmaceutical Science (Q4)
749;5000158120;Pharmacy News;journal;1448207X;0.102;Q4;1;0;342;0;2;155;0.01;0;United Kingdom;Western Europe;Reed Business Publishing;2006-2009;"Pharmaceutical Science (Q4); Pharmacology (nursing) (Q4)"
750;25196;Revista Brasileira de Toxicologia;journal;14152983;0.102;Q4;7;0;12;0;0;12;0;0;Brazil;Latin America;Sociedade Brasileira de Toxicologia;2000-2010;Toxicology (Q4)
751;5800207507;Side Effects of Drugs Annual;book series;03786080;0.102;Q4;6;53;157;4034;4;53;0.02;76.11;Netherlands;Western Europe;Elsevier;1977-1995, 1997-2005, 2007-2012, 2014-2020;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
752;4100151606;Actualites Pharmaceutiques Hospitalieres;journal;17697344;0.101;Q4;3;3;95;0;3;82;0.05;0;France;Western Europe;Elsevier Masson s.r.l.;2005-2012;Pharmaceutical Science (Q4)
753;19430;Adverse Drug Reaction Bulletin;journal;21597774, 00446394;0.101;Q4;7;6;18;222;1;18;0;37;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1970, 1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
754;21100229867;AWWA 2010 Inorganic Contaminants Workshop;conference and proceedings;-;0.101;-;1;0;29;0;0;28;0;0;United States;Northern America;;;"Health, Toxicology and Mutagenesis; Toxicology"
755;21100195303;Eurasian Journal of Analytical Chemistry (discontinued);journal;13063057;0.101;Q4;16;18;22;408;4;22;0.18;22.67;Turkey;Middle East;Moment Publications;2010-2018, 2020;"Analytical Chemistry (Q4); Electrochemistry (Q4); Pharmaceutical Science (Q4); Spectroscopy (Q4)"
756;21100202747;GMP Review;trade journal;14764547;0.101;Q4;2;23;17;87;1;17;0.06;3.78;United Kingdom;Western Europe;Euromed Communications Ltd;2011-2015, 2017-2021;Pharmaceutical Science (Q4)
757;15323;Journal of Jilin University Medicine Edition;journal;1671587X;0.101;Q4;7;269;768;3876;10;768;0.01;14.41;China;Asiatic Region;Jilin University Press;2005-2021;Pharmacology (Q4)
758;21100301603;National Journal of Physiology, Pharmacy and Pharmacology (discontinued);journal;23204672, 22313206;0.101;Q4;13;28;16;627;3;14;0.19;22.39;India;Asiatic Region;Mrs Dipika Charan for MedScience Publishers;2011-2017;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Physiology (Q4)"
759;21100451405;Natural Products Journal;journal;22103163, 22103155;0.101;Q4;13;49;18;1539;0;17;0;31.41;Netherlands;Western Europe;Bentham Science Publishers B.V.;2011-2021;"Complementary and Alternative Medicine (Q4); Drug Discovery (Q4)"
760;19700175580;PharmacoVigilance Review;journal;17526752;0.101;Q4;2;20;46;70;0;31;0;3.5;United Kingdom;Western Europe;Euromed Communications;2010-2019;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
761;21227;Pharmacy in Practice;journal;13581538;0.101;Q4;5;0;26;0;0;23;0;0;United Kingdom;Western Europe;Medicom Publishing;1995-2009;"Health Policy (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
762;19700174966;Pharmakeftiki;journal;22413081, 11054999;0.101;Q4;5;14;15;672;0;15;0;48;Greece;Western Europe;Zita Medical Managent;2008-2010, 2012-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
763;19700175018;Psychopharmacology and Biological Narcology;journal;16068181, 20705670;0.101;Q4;3;1;15;24;0;15;0;24;Russian Federation;Eastern Europe;JSC;2009-2012;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
764;19700194018;Russian Journal of Biopharmaceuticals (discontinued);journal;20738099;0.101;Q4;6;30;35;1027;2;34;0.06;34.23;Russian Federation;Eastern Europe;Folium Publishing Company;2011-2021;"Bioengineering (Q4); Drug Discovery (Q4)"
765;19700182251;Air and Waste Management Association - Harmonizing Greenhouse Gas Assessment and Reporting Processes 2009;conference and proceedings;-;0.1;-;0;0;44;0;0;42;0;0;United States;Northern America;;;"Ecology; Pollution; Toxicology; Waste Management and Disposal"
766;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0.1;Q4;11;0;39;0;0;39;0;0;Turkey;Middle East;University of Ankara;1997-2001, 2003-2010, 2014, 2016-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
767;19700173109;Contract Pharma;trade journal;15443469, 23806559;0.1;Q4;4;159;406;148;5;335;0.02;0.93;United States;Northern America;Contract Pharma;2009-2018;"Industrial Relations (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
768;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;0.1;Q4;3;65;200;163;1;198;0.01;2.51;United Kingdom;Western Europe;Samedan Ltd;2002-2016;Pharmaceutical Science (Q4)
769;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.1;Q4;5;29;129;752;1;125;0;25.93;Bulgaria;Eastern Europe;PHARMAKON-Press;1989-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
770;5100154302;European Biotechnology Science and Industry News;journal;16188276;0.1;Q4;2;64;119;9;2;96;0.01;0.14;Germany;Western Europe;Biocom AG;2006-2013;"Biotechnology (Q4); Drug Discovery (Q4)"
771;19700174996;European Life Science Journal;trade journal;20001444;0.1;Q4;1;0;137;0;0;119;0;0;Norway;Western Europe;International Business Media AB;2009-2011;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
772;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;0.1;Q4;9;0;88;0;3;88;0.02;0;India;Asiatic Region;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-2021;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
773;19700169211;Life Science Clusters;trade journal;17528119;0.1;Q4;0;0;71;0;0;65;0;0;United Kingdom;Western Europe;Avakado Ltd;2009-2010;"Biotechnology (Q4); Industrial Relations (Q4); Management of Technology and Innovation (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
774;21077;Pharmaca;journal;00316857;0.1;Q4;5;0;45;0;0;39;0;0;Croatia;Eastern Europe;Udruzenje Organizacija Zdravstva Hrvatske;1989-2011;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
775;19700174975;Pharmaceutical Formulation and Quality;trade journal;15312135, 19363435;0.1;Q4;1;47;89;271;1;83;0.01;5.77;United States;Northern America;Wiley-Blackwell;2010-2012;Pharmaceutical Science (Q4)
776;19700181430;Pharmaceutical Manufacturing and Packing Sourcer;trade journal;14631245;0.1;Q4;3;64;215;92;3;213;0.02;1.44;United Kingdom;Western Europe;Samedan Ltd;2009-2016, 2018-2019;"Pharmaceutical Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
777;16800154712;Sp2;trade journal;1476184X;0.1;Q4;2;21;189;24;0;169;0;1.14;United Kingdom;Western Europe;Avakado Ltd;2009-2014;"Drug Discovery (Q4); Molecular Medicine (Q4)"
778;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790, 21684804;0.1;Q4;46;87;440;1689;122;408;0.26;19.41;United States;Northern America;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-2021;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4)"
779;20700195026;Acta Pharmaceutica Sinica B;journal;22113843, 22113835;;-;65;5;0;76;0;0;0;15.2;Netherlands;Western Europe;Elsevier BV;2012, 2014-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
780;21100225611;Advanced healthcare materials;journal;21922640, 21922659;;-;105;93;0;5220;0;0;0;56.13;United Kingdom;Western Europe;John Wiley and Sons Ltd;2012-2021;"Biomaterials; Biomedical Engineering; Pharmaceutical Science"
781;21100853016;Antibodies;journal;20734468;;-;15;16;0;1352;0;0;0;84.5;Switzerland;Western Europe;MDPI AG;2017-2021;"Drug Discovery; Immunology; Immunology and Allergy"
782;21100219314;Applied and Translational Genomics;journal;22120661;;-;21;8;0;240;0;0;0;30;Netherlands;Western Europe;Elsevier BV;2012-2016;"Biotechnology; Molecular Biology; Pharmaceutical Science"
783;21100228007;Archives of Razi Institute;journal;20089872, 03653439;;-;10;24;0;572;0;0;0;23.83;Iran;Middle East;Razi Vaccine and Serum Research Institute;2012-2021;"Immunology and Microbiology (miscellaneous) ; Toxicology; Veterinary (miscellaneous)"
784;21100218055;"BMC pharmacology &amp; toxicology";journal;20506511;;-;34;21;0;746;0;0;0;35.52;United Kingdom;Western Europe;BioMed Central Ltd.;2012-2021;"Medicine (miscellaneous); Pharmacology; Pharmacology (medical)"
785;21101021640;Chinese Herbal Medicines;journal;16746384;;-;14;50;0;1201;0;0;0;24.02;Netherlands;Western Europe;Elsevier BV;2012, 2016, 2018-2021;"Complementary and Alternative Medicine; Pharmacology; Pharmacology (medical)"
786;21100262305;Clinical Pharmacology in Drug Development;journal;21607648, 2160763X;;-;26;22;0;397;0;0;0;18.05;United States;Northern America;Wiley-Blackwell;2012-2021;"Pharmaceutical Science; Pharmacology (medical)"
787;21100782803;Current Psychopharmacology;journal;22115560, 22115579;;-;4;1;0;69;0;0;0;69;Netherlands;Western Europe;Bentham Science Publishers B.V.;2012, 2015-2016;"Pharmacology; Pharmacology (medical); Psychiatry and Mental Health"
788;21101055116;Current Reviews in Clinical and Experimental Pharmacology;journal;27724328, 27724336;;-;43;34;98;2712;252;95;2.6;79.76;United Arab Emirates;Middle East;Bentham Science Publishers;2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
789;21100202909;Drug Invention Today (discontinued);journal;09757619;;-;20;90;0;2205;0;0;0;24.5;India;Asiatic Region;Association of Pharmaceutical Innovators;2012-2021;Drug Discovery
790;4700152278;Drugs in Context;journal;17404398, 17451981;;-;26;3;0;310;0;0;0;103.33;United Kingdom;Western Europe;BioExcel Publishing Ltd.;2006-2008, 2012-2021;"Molecular Medicine; Pharmacology"
791;21100232818;Emerging Microbes and Infections;journal;22221751;;-;68;29;0;1441;0;0;0;49.69;United Kingdom;Western Europe;Nature Publishing Group;2012-2021;"Drug Discovery; Epidemiology; Immunology; Infectious Diseases; Medicine (miscellaneous); Microbiology; Parasitology; Virology"
792;21100938253;Environmental Pollutants and Bioavailability;journal;26395940, 26395932;;-;33;31;88;1298;53;88;0.73;41.87;United Kingdom;Western Europe;Taylor and Francis Ltd.;2019-2021;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Toxicology"
793;21100258853;F1000Research;journal;20461402;;-;72;47;0;1266;0;0;0;26.94;United Kingdom;Western Europe;;2012-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Immunology and Microbiology (miscellaneous) ; Medicine (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
794;21100225613;Human gene therapy methods;journal;19466536, 19466544;;-;31;39;0;1614;0;0;0;41.38;United States;Northern America;Mary Ann Liebert Inc.;2012-2019;"Applied Microbiology and Biotechnology; Genetics; Genetics (clinical); Molecular Medicine; Pharmacology"
795;21100200427;Human Vaccines and Immunotherapeutics;journal;21645515, 2164554X;;-;69;318;0;10937;0;0;0;34.39;United States;Northern America;Landes Bioscience;2012-2021;"Immunology; Immunology and Allergy; Medicine (miscellaneous); Pharmacology"
796;21100440523;Interaction Design and Architecture(s);journal;18269745, 22832998;;-;14;15;0;389;0;0;0;25.93;Italy;Western Europe;ASLERD;2012-2021;"Architecture; Computer Science Applications; Human-Computer Interaction; Media Technology; Pharmacology; Social Sciences (miscellaneous)"
797;21100790356;International Journal of Life Sciences Biotechnology and Pharma Research;journal;22503137;;-;1;1;0;11;0;0;0;11;India;Asiatic Region;;2012, 2014, 2016;"Applied Microbiology and Biotechnology; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
798;21100785532;International Journal of Pharma Medicine and Biological Sciences;journal;22785221;;-;1;1;0;20;0;0;0;20;India;Asiatic Region;;2012, 2016;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Medicine (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
799;21100293201;International Journal of Research in Ayurveda and Pharmacy (discontinued);journal;22774343, 22293566;;-;13;194;0;3847;0;0;0;19.83;India;Asiatic Region;Moksha Publishing House;2012-2016;"Drug Discovery; Pharmaceutical Science"
800;21100902935;Journal of Biologically Active Products from Nature;journal;22311874, 22311866;;-;13;45;37;1587;5;37;0.14;35.27;United Kingdom;Western Europe;Taylor and Francis Ltd.;2011-2021;"Agricultural and Biological Sciences (miscellaneous); Complementary and Alternative Medicine; Drug Discovery; Pharmacology; Plant Science; Toxicology"
801;27767;Journal of Forensic Medicine and Toxicology;journal;09711929;;-;18;45;87;627;13;87;0.08;13.93;India;Asiatic Region;;1997-2020;"Pathology and Forensic Medicine; Toxicology"
802;21100220486;Journal of Pharmaceutical Investigation;journal;20935552, 20936214;;-;31;48;0;1219;0;0;0;25.4;Netherlands;Western Europe;Springer Netherlands;2012-2021;"Pharmaceutical Science; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
803;21100399725;Journal of Reports in Pharmaceutical Sciences;journal;23225106, 23221232;;-;9;16;0;389;0;0;0;24.31;Iran;Middle East;Wolters Kluwer Medknow Publications;2012-2021;"Biomedical Engineering; Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
804;21100928216;Journal of Research in Pharmacy;journal;26306344;;-;16;28;44;1200;41;44;0.93;42.86;Turkey;Middle East;Marmara University;2019-2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
805;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;26;243;657;5593;232;657;0.33;23.02;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-2021;"Drug Discovery; Pharmaceutical Science"
806;19700182629;Methods in Pharmacology and Toxicology;book series;15572153, 19406053;;-;10;45;0;2843;0;0;0;63.18;United States;Northern America;Humana Press;2008, 2012, 2014-2021;"Molecular Medicine; Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
807;21100218543;Molecular Therapy - Nucleic Acids;journal;21622531;;-;71;64;0;2413;0;0;0;37.7;United States;Northern America;Cell Press;2012-2021;"Drug Discovery; Molecular Medicine"
808;21100924771;Natural Products and Bioprospecting;journal;21922209, 21922195;;-;26;45;25;1288;18;25;0.72;28.62;Singapore;Asiatic Region;Springer Singapore;2011-2021;"Analytical Chemistry; Biochemistry; Food Science; Organic Chemistry; Pharmacology; Plant Science; Toxicology"
809;21100318814;Pharmaceutical patent analyst;journal;20468954, 20468962;;-;17;42;0;442;0;0;0;10.52;United Kingdom;Western Europe;Future Science;2012-2018, 2021;"Drug Discovery; Medicine (miscellaneous); Pharmaceutical Science"
810;21101055117;Recent Advances in Anti-Infective Drug Discovery;journal;27724352, 27724344;;-;33;27;65;2250;162;64;2.82;83.33;United Arab Emirates;Middle East;Bentham Science Publishers;2021;"Drug Discovery; Infectious Diseases; Pharmacology (medical)"
811;24032;Reviews of Physiology Biochemistry and Pharmacology;journal;16175786, 03034240;;-;66;10;0;1845;0;0;0;184.5;Germany;Western Europe;Springer Verlag;1974-2008, 2012-2018;"Biochemistry; Medicine (miscellaneous); Pharmacology; Physiology; Physiology (medical)"
812;21100977423;RSC Medicinal Chemistry;journal;26328682;;-;62;208;219;8494;592;212;2.7;40.84;United Kingdom;Western Europe;Royal Society of Chemistry;2020-2021;"Biochemistry; Drug Discovery; Molecular Medicine; Organic Chemistry; Pharmaceutical Science; Pharmacology"
813;19700180781;Strategies and Tactics in Organic Synthesis;book series;18746004;;-;10;17;0;1143;0;0;0;67.24;United States;Northern America;Academic Press Inc.;2004-2005, 2008, 2012-2017, 2019;"Drug Discovery; Organic Chemistry"
814;19700180785;Studies in Natural Products Chemistry;book series;15725995;;-;41;40;0;4190;0;0;0;104.75;Netherlands;Western Europe;Elsevier;1995-1997, 2000-2003, 2005-2006, 2008, 2012-2021;"Drug Discovery; Organic Chemistry"
815;21100207003;Theranostics;journal;18387640;;-;115;106;0;6517;0;0;0;61.48;Australia;Pacific Region;Ivyspring International Publisher;2012-2021;"Medicine (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
816;21100787110;Therapeutic Advances in Psychopharmacology;journal;20451261, 20451253;;-;26;37;26;974;13;19;0.5;26.32;United States;Northern America;SAGE Publications Inc.;2011-2015;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Psychology (miscellaneous)"
817;21100241601;Toxicology Research;journal;2045452X, 20454538;;-;37;23;0;1605;0;0;0;69.78;United Kingdom;Western Europe;Oxford University Press;2012-2021;"Health, Toxicology and Mutagenesis; Toxicology"
818;21100208082;VacciMonitor;journal;10250298, 1025028X;;-;5;22;0;436;0;0;0;19.82;Cuba;Latin America;Instituto Finlay, Centro de Investigacion-Produccion de Vacunas y Sueros;2012-2021;"Drug Discovery; Immunology; Immunology and Allergy; Molecular Medicine"
819;21100218529;Value in Health Regional Issues;journal;22121099, 22121102;;-;21;43;0;1089;0;0;0;25.33;United States;Northern America;Elsevier USA;2012-2021;"Economics, Econometrics and Finance (miscellaneous); Health Policy; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
